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Abstract
The syndrome of apathy, defined as a reduction in goal-directed behavior (GDB), has profound
consequences for morbidity and mortality in the patient and for family-caregiver burden. Apathy is one of
the primary neuropsychiatric syndromes associated with the disruption of the frontal-striatal system, but
the behavioral and biological mechanisms underlying apathy are not well understood. Apathy is especially
prevalent in behavioral variant frontotemporal degeneration (bvFTD). In a sample of 20 apathetic adults
with bvFTD and 17 normal controls (NC), impairments in three components of GDB--initiation, planning
and motivation--were examined using a novel computerized reaction time test. Employing structural
neuroimaging techniques, I then examined the neural basis of GDB in these apathetic bvFTD participants.
I found evidence that apathy is associated with an impairment in any of the three GDB components.
Initiation, planning, and motivation each map onto three distinct brain regions in the frontal lobe that work
together in a large-scale neural network. Furthermore, I was able to identify participants with specific
subtypes of apathy, depending on the impaired GDB mechanism. I developed and submitted a proposal
for continued study of the phenomenon; the proposal was awarded. The long-term potential impact of
this beginning program of research is profound for patients with neurodegenerative disease, their
caregivers, and families. Current treatment of apathy has been hindered due to poor understanding of the
mechanisms underlying this condition. This work will lead to a better understanding of these
mechanisms and structures fundamental to the behavior, and, with this knowledge, tailored interventions
can be designed and implemented by professional and lay caregivers. Thus, a more precise
characterization of apathy will allow providers to implement the most appropriate therapy for a given
patient.
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ABSTRACT
THE COGNITIVE AND NEURAL BASIS FOR APATHY IN
FRONTOTEMPORAL DEGENERATION
Lauren M. Massimo
Lois K. Evans
The syndrome of apathy, defined as a reduction in goal-directed behavior (GDB), has
profound consequences for morbidity and mortality in the patient and for familycaregiver burden. Apathy is one of the primary neuropsychiatric syndromes associated
with the disruption of the frontal-striatal system, but the behavioral and biological
mechanisms underlying apathy are not well understood. Apathy is especially prevalent in
behavioral variant frontotemporal degeneration (bvFTD). In a sample of 20 apathetic
adults with bvFTD and 17 normal controls (NC), impairments in three components of
GDB—initiation, planning and motivation—were examined using a novel computerized
reaction time test. Employing structural neuroimaging techniques, I then examined the
neural basis of GDB in these apathetic bvFTD participants. I found evidence that apathy
is associated with an impairment in any of the three GDB components. Initiation,
planning, and motivation each map onto three distinct brain regions in the frontal lobe
that work together in a large-scale neural network. Furthermore, I was able to identify
participants with specific subtypes of apathy, depending on the impaired GDB
mechanism. I developed and submitted a proposal for continued study of the
phenomenon; the proposal was awarded. The long-term potential impact of this
beginning program of research is profound for patients with neurodegenerative disease,
their caregivers, and families. Current treatment of apathy has been hindered due to poor
vi	
  

understanding of the mechanisms underlying this condition. This work will lead to a
better understanding of these mechanisms and structures fundamental to the behavior,
and, with this knowledge, tailored interventions can be designed and implemented by
professional and lay caregivers. Thus, a more precise characterization of apathy will
allow providers to implement the most appropriate therapy for a given patient.
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CHAPTER 1: INTRODUCTION
The syndrome of apathy, defined as a reduction in self-generated or voluntary
behavior (Levy & Dubois, 2006), has profound consequences for morbidity and mortality
in patients with neurodegenerative disease (ND) and contributes significantly to family
caregiver burden (Butterfield, Cimino, Oelke, Hauser, & Sanchez-Ramos, 2010; Chio et
al., 2010; Karttunen et al., 2010). Apathy is especially prevalent in behavioral variant
Frontotemporal degeneration (bvFTD), where it is reported in up to 90.5% of mild-stage
patients (Diehl-Schmid, Pohl, Perneczky, Forstl, & Kurz, 2006).
FTD is the second most common young-onset ND (Ratnavalli, Brayne, Dawson,
& Hodges, 2002; Rosso et al., 2003). Neuronal loss in the frontal and temporal lobes of
the brain results in difficulty regulating social behavior (Massimo & Grossman, 2008). In
the field of ND, abnormal social behavior includes a wide range of neuropsychiatric
symptoms that are disruptive to social interaction (Massimo, Evans, & Benner, 2013).
Abnormal social behavior is the hallmark symptom of bvFTD, with the syndrome of
apathy being the most common, evident pervasively throughout the duration of the
disease (Le Ber et al., 2006; Mendez, Lauterbach, & Sampson, 2008). Although apathy in
bvFTD is a very common and significant problem, the mechanisms contributing to this
behavior rarely have been studied. At present, no proven effective treatments exist for
apathy, in part because the underlying dysfunction is not fully understood (Chase, 2011).
Thus, the purpose of this study was to advance understanding of mechanisms
contributing to apathy to improve outcomes for those suffering its consequences.
The concept of goal-directed behavior (GDB) provides a useful model for
examining the mechanisms underlying apathy. In neuroscience, GDB is used to
	
  

2
operationalize a broad spectrum of purposeful actions and their determinants (Brown &
Pluck, 2000), related to the belief that when action a is taken, goal x may be obtained as a
result. The GDB model was proposed by Levy and Dubois (2006) to improve
understanding of the mechanisms that contribute to the loss of self-initiated behavior
referred to as “apathy.” Despite urging from caregivers, pain, and risk of death, patients
with apathy do not initiate GDB.
Three distinct components of GDB are initiation, planning, and motivation
(Brown & Pluck, 2000). Each component of GDB is supported by a distinct anatomic
circuit centered on a specific portion of the prefrontal cortex. Apathy is hypothesized to
emerge where there is dysfunction of any one of these components (Levy & Dubois,
2006). Using neurobiological tools, such as quantitative brain imaging, to study patients
with apathy strongly suggests an anatomic basis for the mechanisms contributing to
apathy (Massimo et al., 2009; Rosen et al., 2005; Zamboni, Huey, Krueger, Nichelli, &
Grafman, 2008). Therefore, I proposed to use the GDB model to examine the brainbehavior relationships underlying apathy in bvFTD. Specifically, I conducted an
empirical study that quantified difficulty with each component of GDB using a novel
computerized reaction-time test, examined the distinct prefrontal neuroanatomical
substrates of these impairments in an apathetic bvFTD sample using regression, and then
related specific apathetic behaviors to grey matter atrophy and white matter integrity,
quantified by magnetic resonance imaging (MRI).
Study Significance
The following case captures the problem this research addressed:
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BJ is a 58-year-old female with FTD. Her husband notes that “it is impossible to
get her going.” She sits and watches static on the television all day long and her
husband rarely sees her move spontaneously. She has developed pressure ulcers
because of her lack of movement: Neither urgent prompts from her husband nor
the pressure ulcer associated pain has been successful in compelling her to move.
Her husband is very distressed about his wife’s behavior and wants to know,
“Why does she just sit there?” Of note, her Mini-Mental State Exam (MMSE)
score is 28 of 30 (“no impairment”).
BJ’s case demonstrates the significant problems that can occur when someone is
apathetic. The goal of this research was to help answer questions about why apathy
occurs in individuals with bvFTD. Apathy is a very common neuropsychiatric syndrome
negatively affecting patient and caregiver outcomes (Chio et al., 2010; Karttunen et al.,
2010) including increased patient mortality (Vilalta-Franch, Calvo-Perxas, Garre-Olmo,
Turro-Garriga, & Lopez-Pousa, 2013). Apathy is associated with a variety of undesirable
consequences in patients, such as poor insight and poor cognitive performance (Chase,
2011; Ishii, Weintraub, & Mervis, 2009; Pedersen, Alves, Aarsland, & Larsen, 2009;
Pluck & Brown, 2002). The deficits observed in apathetic patients such as poor planning,
poor motivation, and the inability to initiate even the simplest self-care activities
contribute to functional deterioration (Pedersen, Alves, et al., 2009). These findings
suggest that apathy contributes significantly to global decline and mortality, and support
the need for its identification and proper management in at-risk patient populations.
Caring for a person with apathy is challenging. The physical and emotional
demands associated with performing many activities for persons with apathy are
profound. High levels of depression, burden, and stress have been reported in caregivers
of apathetic patients (Chio et al., 2010; Massimo et al., 2009).
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Apathetic bvFTD patients, in particular, lack insight into their social difficulties
and are unaware of the consequences of their behavior (Eslinger et al., 2005; Massimo,
Libon, et al., 2013). Their caregivers often misinterpret apathy as a sign of oppositional
or volitional behavior, leading to dissatisfaction with caregiving (Landes, Sperry, Strauss,
& Geldmacher, 2001; Massimo, Evans, et al., 2013). A study of 53 spousal caregivers
demonstrated that apathetic behavior had the greatest impact on the decline of the marital
relationship (de Vugt et al., 2006). This impact has significant implications for caregiver
burnout because it is the bond between caregiver and care recipient that sustains
caregiving under adverse conditions (Wrubel & Folkman, 1997).
Treatments for apathy have heretofore been ineffective. In a recent systematic
review of pharmacological treatments, there was insufficient evidence to support the use
of medications for the improvement of apathy in ND (Drijgers, Dujardin, Reijnders,
Defebvre, & Leentjens, 2010). One reason for these failures may be the way apathy is
currently conceptualized. That is, apathy is viewed homogeneously, as if derived simply
from a lack of motivation (Marin, 1996). There is evidence to suggest several different
mechanisms contribute to apathy, including deficits in initiation and planning, as well as
motivation (Chow et al., 2009; Eslinger, Moore, Antani, Anderson, & Grossman, 2012;
Levy & Dubois, 2006; Massimo et al., 2009). Additionally, there is neuroanatomical
evidence to support a multicomponent approach to apathy. Several neuroimaging studies
associate apathy with numerous regions in the frontal cortex (Massimo et al., 2009;
Rosen et al., 2005; Zamboni et al., 2008). Mechanisms underlying apathy are
qualitatively different, and, thus, may require distinct interventions. Knowledge of
distinct subtypes of apathy would help explain treatment failures that may be due, at least
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in part, to the attempt to treat all apathy with a single approach. For example, when
apathy emerges in response to planning difficulties, there is benefit to be gained from
structuring the activity in a simple way for the patient. For patients with impaired goalselection, modifications such as amplified lighting in a room may increase the reward
potential of the environment (Ishii et al., 2009). Last, multisensory stimulation (MSS), a
therapeutic approach that provides visual, auditory, tactile, and olfactory stimulation, may
be helpful for patients with initiation difficulty (Baker et al., 2001); the use of MSS in a
patient with planning difficulty, however, may worsen rather than improve apathy.
Additionally, apathy is often ignored by clinicians because of patients’ lack of apparent
distress (Butterfield et al., 2010). One of the primary obstacles in furthering the research
in this area has been the absence of an empirically-based approach that can elucidate the
mechanisms contributing to apathy. This research, thus, aimed to fill this gap by applying
a model of GDB in persons with bvFTD where apathy is highly prevalent. This work,
which attempted to understand the cognitive and neural basis for apathy, represents the
first step to support the development of rational treatment for patients with various
subtypes of apathy.
The potential long-term impact of this work is significant. This research holds
promise for changing the way in which nurses and other health professionals currently
view, evaluate, and treat apathy in patients with ND, as well as in other neuropsychiatric
conditions. The pathophysiological model resulting from this work, revealing several
mechanisms contributing to apathy, may lead to improved treatment using tailored
biobehavioral interventions that target the impairments in GDB. In addition to direct
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clinical benefits, the knowledge gained from this work will advance neurocognitive
models of social behavior. Thus, The aims of this study were:
Specific Aims
Aim 1: To relate impairments in GDB (initiation, planning, and motivation) in
bvFTD to distinct neuroanatomic regions in the prefrontal cortex.
H1: Poor initiation is related to grey matter atrophy in the anterior cingulate
cortex (ACC) and to reduced white matter integrity in the cingulum.
H2: Poor planning is related to grey matter atrophy in the dorsolateral prefrontal
cortex (dlPFC) and to reduced white matter integrity in the superior
longitudinal fasciculus.
H3: Poor motivation is related to grey matter atrophy in the orbital-frontal cortex
(OFC) and to reduced white matter integrity in the uncinate fasciculus.
Aim 2: To differentiate three apathetic subtypes based on impaired components of
GDB in bvFTD using a novel computerized reaction time test (Philadelphia Apathy
Computerized Test [PACT]) and to examine regional grey matter volume underlying
these impairments.
H1: Participants with bvFTD will have greater difficulty with initiation than
normal controls (NC). Moreover, I will identify a subtype of bvFTD
participants with a specific deficit of initiation who will have significantly
slower initiation times on the simple condition of the PACT compared to NC.
Participants with initiation difficulty will have significantly reduced ACC
grey matter values compared to a control brain region.
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H2: Participants with bvFTD will have greater difficulty with planning than NC.
Moreover, I will identify a subtype of bvFTD participants with a specific
planning deficit who will have significantly greater slowing on the complex
planning condition, contrasted with the simpler planning condition of the
PACT compared to NC. Participants with planning difficulty will have
significantly reduced dlPFC grey matter values compared to a control brain
region.
H3: Participants with bvFTD will have greater difficulty with motivation than NC.
Moreover, I will identify a subtype of bvFTD participants with a specific
deficit of motivation who will fail to respond to penalizing motivators in the
simple condition compared to NC. Participants with motivation difficulty will
have significantly reduced OFC grey matter values compared to a control
brain region.
Aim 3: To develop a proposal, based on findings from Aims 1 and 2, which will
improve understanding of apathy by examining mechanisms of longitudinal decline and
neural compensation.
GDB allows people to be independent in everyday task performance. This
research advances models of social neuroscience by examining cognitive and neural
bases to understand a key aspect of human behavior. Moreover, the results will help
change the paradigm to assess and treat apathy in ND, leading to improved diagnostic
accuracy and effective interventions. This outcome will greatly improve the ability of
families, nurses, and other health professionals to manage a pervasive feature of ND.
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Background
Definition of apathy. The word apathy derives from the Greek word pathos or
passion. It describes a state of indifference or inertia (Robert et al., 2009). Over time the
concept of apathy has undergone changes in meaning, and remains vaguely defined and
broadly applied (Chase, 2011). Sometimes described as a symptom of other disorders
such as depression, Marin (1990) clarified the concept of apathy for medical purposes by
proposing its definition as a lack of motivation. Marin suggested that apathy is a
syndrome or dimension of behavior that results from psychiatric, neurologic, or medical
disorders. One problem with Marin’s definition is that lack of motivation is not the only
mechanism that contributes to apathetic behavior; “lack of motivation” is not easily
quantifiable. In 2006, Levy and DuBois (2006) proposed to define apathy as the
quantitative reduction of self-generated voluntary and purposeful GDB. Their definition
informed the current study. From this perspective, it is possible to observe and measure
the various mechanisms contributing to apathy. Furthermore, it may be possible to
operationalize these underlying mechanisms and postulate “subtypes” of apathy based on
impaired GDB.
A new consensus for the clinical diagnosis of apathy in neurodegenerative
conditions has been proposed by an international task force (Robert et al., 2009). To meet
criteria, the patient must meet the following requirements: the core feature of diminished
motivation must be present for at least 4 weeks, there must be a reduction in two of three
domains, and there must be a functional impairment attributed to the behavior. Domain 1
refers to reduced GDB, describing the loss of self-initiated behavior (e.g., starting a
conversation) and loss of environment-stimulated behavior (e.g., responding to
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conversation). Domain 2 refers to a reduction in goal-directed cognitive behavior,
describing a loss of ideas and curiosity for new routines (e.g., recent news or social
opportunities). Domain 3 refers to a reduction in emotion, describing a loss of
spontaneous emotion or loss of emotional responsiveness to positive or negative stimuli
(e.g., little reaction to exciting news). A reliable clinical diagnosis of apathy is necessary
to identify its presence and to distinguish it from other clinical syndromes such as
depression. These criteria, however, focus solely on clinical presentation of apathy. This
dissertation goes beyond providing a clinical description of apathy; the intent is to
understand the different mechanisms that underlie apathy so that meaningful treatment,
based on specific impaired mechanisms, can be pursued.
Thus, in this dissertation, I examined the GDB model, applied to apathy, to
identify the underlying mechanisms (Aim 1), and I operationalized the underlying
mechanisms to postulate “subtypes” of apathy (Aim 2). Last, the findings from Aims 1
and 2 informed a proposal for future work in which I intend to examine the trajectory of
apathy and identify factors that moderate the progression of this devastating
neuropsychiatric syndrome (Aim 3). The literature for this chapter was selected from
search results using CINAHL, EMBASE, Medline, PubMed, PsycINFO, Cochrane
Reviews, and a hand search of the reference lists from articles. Selected articles included
randomized-controlled trials, descriptive studies, and reviews. Although it may be useful
to investigate neurochemistry as it relates to apathy, this area of inquiry was beyond the
scope of this dissertation study.
Hypothesized model of apathy. Apathy can be explained and examined as part
of the concept of GDB. GDB is operationalized as a “broad spectrum of purposeful
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actions and their determinants, from the simplest movement to the most complex patterns
of behavior” (Brown & Pluck, 2000, p. 416). This is related to the belief that when action
a is taken, goal x may be obtained as a result. Central to GDB is the integration of the
processes that influence a person to act (intention). According to the model, three
processes (initiation, planning, and motivation) influence the intention to act. Although
each step is necessary to achieve GDB, clinical observations of patients with ND suggest
that these processes may not be sequential. In the hypothesized model, apathy arises
when any one of these three processes is impaired. For example, patients who have
profound impairments in the executive abilities needed to design and carry out plans of
action may be motivated to engage in GDB, but their planning impairments make it
difficult to engage in GDB. Therefore, it is likely that each process is independent and,
when compromised, contributes to apathy.
These three processes of GDB map onto three distinct networks of brain regions.
In particular, neuroimaging studies in patients have linked apathy to specific regions in
the prefrontal cortex, anterior cingulate, and basal ganglia. G. E. Alexander, DeLong, and
Strick (1986) were first to describe the five circuits (two motor and three behavioral)
linking the basal ganglia and frontal cortex. The three functional neuroanatomic loops in
the frontal area (anterior cingulate circuit, dorsolateral prefrontal circuit, and orbitofrontal
circuit) capture the information from internal and external environments needed to make
a decision about possible actions to be performed, likely important to GDB. Each circuit
is functionally separate and mediates in its own way. This dissertation study focused on
the three functional neuroanatomic loops—anterior cingulate circuit, dlPFC circuit, and
orbitofrontal circuit—and their relationship to initiation, planning, and motivation.
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Frontotemporal degeneration. FTD is an ND that mainly affects the frontal and
temporal lobes of the brain. This condition affects individuals at a young age, typically
presenting in the fifth or sixth decade of life (Massimo & Grossman, 2008; Rosso et al.,
2003). FTD is recognized as the most common young onset dementia with prevalence
ranging from 15–22 per 100,000 cases per year (Knopman & Roberts, 2011). These
numbers are likely to be an underestimate, as the disorder is difficult to diagnose and
requires a level of expertise in behavioral neurology. Clinically, bvFTD presents with
difficulty regulating social behaviors such as disinhibition and apathy and a profound loss
of insight (Rascovsky et al., 2011). One large autopsy-confirmed study demonstrated the
frequency of behavioral symptoms in bvFTD to be between 59% to 84%, with apathy
most frequent (Rascovsky et al., 2011). These behaviors significantly impact everyday
functions and contribute to caregiver distress (Massimo et al., 2009; Mioshi & Hodges,
2009). Thus, it is important to understand apathy for the optimal management of patients.
Apathy in neurodegenerative disease. In addition to FTD, apathy is also
common in other neurodegenerative disorders such as Alzheimer’s disease (AD), FTD,
Lewy Body Disease, and Parkinson’s disease (PD; Clarke et al., 2008; Mega, Cummings,
Fiorello, & Gornbein, 1996). In the AD population, the prevalence rate is between 51 and
80% (Aharon-Peretz, Kliot, & Tomer, 2000; Di Iulio et al., 2010; Kaufer et al., 1998).
The frequency of apathy in PD may also be substantial, as estimates of prevalence range
from 12 to 70% (Aarsland et al., 2009; Pedersen, Larsen, Alves, & Aarsland, 2009;
Starkstein et al., 1992).
Abnormal social behavior is a hallmark of FTD. In particular, it has been
suggested that apathy is the most prevalent behavior in FTD, occurring in up to 90.5% of
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mild-stage patients and up to 100% of moderate and severe-stage patients in one study
that evaluated the prevalence of behavioral disturbances in FTD (Diehl-Schmid et al.,
2006). Other authors also reported apathy to be the most common neuropsychiatric
behavior in FTD (Massimo et al., 2009; Peters et al., 2006). Although apathy is often
referenced as a behavior or symptom, this study examines apathy as a syndrome, which
acknowledges heterogeneous behavioral processes and neuroanatomical mechanisms
contributing to the clinical phenomenology.
Evidence from previously reported work suggests that impairments in GDB are
also present in bvFTD patients. Poor motivation may occur in these patients because they
have decreased reactivity to positive and negative signals in social situations. Grossman
and colleagues (2010) recently examined decreased reactivity by asking bvFTD patients
to judge the acceptability of social situations. They found that bvFTD patients were
particularly insensitive to the interpretation of negatively valenced features. Impaired
executive function, a common finding in bvFTD, has also been associated with apathy in
this group (Eslinger, Moore, Anderson, & Grossman, 2011; Eslinger et al., 2012).
Impaired executive function may contribute to apathy because of the inability to carry out
plans of action. Last, although poor initiation has not been explicitly examined in bvFTD,
the anterior cingulate—an area that has been hypothesized to contribute to the loss of
self-initiated thoughts or actions (Levy & Dubois, 2006)—is compromised in apathetic
patients (Massimo et al., 2009).
Depression and apathy are two distinct syndromes that are often confused.
Symptoms that are common to both apathy and depression include hypersomnia and
fatigue (Landes et al., 2001; Mega et al., 1996). Starkstein, Ingram, Garau, and Mizrahi
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(2005) examined the differentiation of apathy and depression using factor analysis of the
Hamilton Depression Scale. They found that dysphoric symptoms such as sad mood, guilt,
suicidal ideation, anxiety, and insomnia loaded as sadness factors, suggesting these were
more commonly found in a depressed patients. Other symptoms such as self-criticism and
negative thoughts about the future were common in depressed patients, but were absent in
apathetic patients who tended to show a lack of concern (Marin, 1996). This is consistent
with similar findings suggesting that apathy is a discrete syndrome separate from
depression (Landes et al., 2001). Because apathy is so common in ND, efforts to
distinguish this syndrome from depression are imperative for clinicians, especially in
guiding treatment decisions.
Voxel-based morphometry. The study of the neuroanatomy of apathy is of
scientific interest because its study can validate the contribution of an impairment of the
three components of GDB to apathy in bvFTD. A large-scale neural network is thought to
support the mechanisms (initiation, planning, and motivation) contributing to apathy by
involving brain regions specific to each process (Levy & Dubois, 2006). By using
neurobiological tools such as voxel brain morphometry (VBM) to study patients with
apathy, the nature and anatomic localization of the mechanisms contributing to apathy
can be identified. Imaging of apathetic patients, thus, allows for the dissociation of
clinical constructs into specific processes (i.e., impairments in initiation, planning, and
motivation) that contribute to behavior like apathy (Nader, Bechara, & van der Kooy,
1997). From this mechanistic perspective, I hypothesized that the physiopathology of
apathy would not be reduced to a single entity, but rather that multiple processes would
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be shown to contribute to apathy. An investigation of each process would directly link to
neuronal mechanisms known to underlie GDB.
Morphometry analysis is a common tool used to measure structural differences in
a group or across groups (Savio et al., 2011). Voxel values are modulated by Jacobian
determinants derived from spatial normalization, which occurs after tissue classes are
segmented (cerebrospinal fluid, grey matter, white matter). When pathology in the brain
structures occurs, there is an impact on the fine morphology of the grey matter and
atrophy, or tissue loss, results. White matter is also susceptible to pathological damage in
bvFTD (Lu et al., 2013). By measuring directional changes in water diffusivity, diffusion
tensor (DT) provides information about the microstructural tissue integrity of white
matter tracts (Whitwell et al., 2010).
Components of goal-directed behavior.
Initiation component. The failure to execute behavior leads to apathy when
processing is unable to generate a signal significant enough to initiate a response.
Difficulty with initiation has been reported in patients with focal lesions in either the
ACC or the basal ganglia. It is important to note that there are interconnections between
the two regions. ACC projects to the striatum (equipped with mechanisms for behavior
selection) and the subthalamic nucleus, both of which are input zones of the basal ganglia
(Hikosaka & Isoda, 2010); then there is a final loop back to the ACC to form a closed
circuit. The failure of the basal ganglia to activate the cortex or the impaired activation of
the motor system following ACC damage can cause difficulties with initiation
(Kotchoubey, Schneck, Lang, & Birbaumer, 2003).
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For example, the akinetic mute state is a medical term describing patients who
tend to sit quietly in the same position all day without speaking or talking. It has been
specifically related to ACC damage (Mega & Cohenour, 1997). Another related term,
abulia, describes a loss of initiative and of spontaneous thought associated with damage
to the basal ganglia (Bhatia & Marsden, 1994). Although these symptoms are thought to
originate from two distinct anatomic structures, they are both symptoms of a failure to
initiate or activate GDB.
The ACC has been well studied in dementia and neuroimaging evaluations have
linked the ACC region to apathy in various groups. Low grey matter density in the
cingulate gyrus was associated with increased severity measures of apathy in PD
(Reijnders et al., 2010). Others have implicated this region in apathetic bvFTD patients
(Massimo et al., 2009; Zamboni et al., 2008). Previous diffusion tensor imaging (DTI)
studies investigating white matter disease and apathy have an association with the
cingulum (Hahn et al., 2013; J. W. Kim et al., 2011; Ota, Sato, Nakata, Arima, & Uno,
2012). Although disease in the ACC and related white matter tracts contributes to apathy
in patients, there have been few evaluations that describe the relationship in initiation of
GDB.
Planning component. The ability to execute an action is highly dependent on the
cognitive processes needed to formulate and carry out goals. Apathy related to “cognitive
inertia” results from impairments in executive functions such as planning, working
memory, and task switching (Levy & Dubois, 2006). These cognitive processes are
needed to organize and structure GDB. The loss of these abilities will quantitatively
reduce behavior.
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Multitasking is an important aspect of executive function, referencing the ability
to carry out several separate tasks concurrently while keeping the goals of each task in
mind. The cognitive demand of multitasking includes selecting, organizing, and
executing numerous tasks in a given time period (Burgess, 2000). Esposito et al. (2010)
recently examined the aspect of multitasking related to apathy in AD patients. They
found that an inability to perform several tasks (measured by rule breaks) was predictive
of a lack of initiative (motivation). This outcome suggests that when patients are faced
with complex problems that are cognitively demanding, they may become overwhelmed
and, thus, less likely to engage in activities. An alternative hypothesis, in contrast to the
findings of Espositio and colleagues, may be that patients perform more poorly because
of other processes like impaired judgment or poor working-memory performance.
Although there seems to be a relationship between apathy and deficits in multitasking,
further studies are needed to determine the exact role of planning in apathy.
Weintraub and colleagues (2005) examined the dimension of executive function
as it relates to apathy in PD patients. They found that poor planning, measured by
standardized tests of planning, was associated with increased severity of apathy. An
important issue that was not addressed by Weintraub et al., however, is the relative
complexity of the plan needed to engage in GDB. Consideration should be given to the
total complexity of a task and the amount of executive resources it demands as it relates
to apathy severity.
The anatomic basis of executive dysfunction has been linked to dorsolateral
portions of prefrontal cortex (dlPFC; Miller & Cohen, 2001). This region has been shown
to play a critical role in planning and working memory. Several investigations have
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demonstrated that working memory is associated with dlPFC (Champod & Petrides,
2007; Funahashi, 2001; Yun, Krystal, & Mathalon, 2010). Garavan, Ross, Li, and Stein
(2000) evaluated the role of working memory by manipulating allocation of attentional
resources in working memory tasks. This technique was used to disentangle working
memory from other executive processes, allowing for a pure analysis of working memory.
Using functional MRI (fMRI) technique, they found that working memory-demanding
tasks activated dlPFC in healthy controls.
Other work also suggested the importance of dlPFC for planning (Kaller, Rahm,
Spreer, Weiller, & Unterrainer, 2011). The planning process can be assessed with
measures like the Tower of London task where participants are asked to preplan mentally
a sequence of moves to match a set goal. Event-related fMRI techniques are employed to
capture planning demands in NC. Using this technique, several studies have
demonstrated the activation of dlPFC in planning tasks (Newman, Carpenter, Varma, &
Just, 2003; Rowe, Owen, Johnsrude, & Passingham, 2001; Unterrainer, Rahm, Kaller,
Leonhart, et al., 2004).
Studies suggested an association between apathy and poor executive function in
bvFTD (Zamboni et al., 2008). Imaging studies of patients with ND have linked apathy to
tissue loss in dlPFC and related white matter tracts including the superior longitudinal
fasciculus (Cacciari et al., 2010; Massimo et al., 2009; Zamboni et al., 2008). Patients
who suffered from dysfunction in these circuits failed to elaborate, manipulate, and
integrate important information needed for behavior that was goal-directed.
Motivation component. Finally, apathy may result from a lack of responsiveness
to either reward or negative-consequence feedback, thereby making goal selection
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difficult (Levy & Dubois, 2006; Rosen et al., 2002). Because rewards and avoidance of
negative consequences constitute basic goals of behavior, motivational functions are
based partly on the processing of reward information (Schultz, Tremblay, & Hollerman,
2000).
Evidence from healthy-subject MRI studies suggested that the OFC is important
to determine information regarding interpretation of reward (Hare, Camerer, Knoepfle, &
Rangel, 2010; Kable & Glimcher, 2007). In an fMRI study of reward processing in
healthy controls, Smith and colleagues (2010) found that the ventromedial prefrontal
cortex (vmPFC) is highly specialized in the way it processes rewards. In particular, they
found that, in vmPFC, the anterior portion experienced value for social and monetary
rewards, whereas the posterior vmPFC tracked the decision value between these two
reward categories. Together, these findings suggest that multiple value signals exist
simultaneously in the anterior and posterior vmPFC, each playing a distinct role in
reward processing.
This region also may mediate the inhibition of inappropriate responses while
facilitating appropriate responses for goal completion (Gill, Castaneda, & Janak, 2010).
This is important to apathy because the inability to suppress the response evoked by a
stimulus in the immediate environment prevents a patient from selecting an appropriate
action plan. Thus, the behavior is controlled by the emotional impact of the stimulus at
hand. Bechara, Damasio, and Damasio (2000) tested this hypothesis in patients with
lesions of vmPFC. Patients participated in a gambling task. Compared to controls,
patients with vmPFC lesions preferred decks with a high immediate reward, even though
the decks with smaller reward were advantageous in the long term. They also preferred
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decks with low immediate punishment to those with higher immediate punishment,
although the higher immediate punishment was more advantageous in the long run. Their
results reinforced the notion that decisions made by patients with vmPFC lesions are
largely based on the immediate prospects and do not consider the severity of future
adverse consequences (Bechara et al., 2000).
Persons with bvFTD have been examined extensively in reward processing
because they have an early degeneration of the associated frontal circuit in comparison to
other neurodegenerative conditions (Rabinovici et al., 2007). Grossman and colleagues
(2010) examined the interpretation of positive and negative situations in bvFTD. They
found bvFTD participants were particularly impaired in interpreting negative
consequences of a social situation (e.g., “Rolling through a red light at 2am when there is
a police car at the intersection”). Their insensitivity to negative consequences may
underlie reduced motivation.
The study of reward processing and resultant apathetic behavior in the bvFTD
population offers essential insights into the functions of the OFC. Experimental evidence
using imaging techniques in patients with bvFTD has emphasized the link between
orbitofrontal regions and apathetic behaviors. Comparison of brain activity between
apathetic and nonapathetic bvFTD participants using positron emission tomography
(PET) data revealed patients have decreased activity in the OFC of apathetic participants
(Peters et al., 2006). Rosen and colleagues (2005) examined apathy, measured by the
Neuropsychiatric Inventory (NPI), and found apathy scores to be independently
associated with atrophy in the ventromedial frontal gyrus. The uncinate (UNC) is a major
tract connecting the anterior temporal lobe with the medial and lateral prefrontal cortex
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(Papagno et al., 2011), areas known to be important for GDB (Kable & Glimcher, 2007).
DTI studies performed in patients with AD and progressive supranuclear palsy (PSP)
implicated UNC in apathy (Hahn et al., 2013; Kvickstrom et al., 2011). The conclusions
from these imaging studies suggested that the OFC and related white matter tracts have a
relationship to apathy, although distinct areas of this region may have specific roles.
Summary of Key Points
Apathy can be viewed as the quantitative reduction of GDB and is a common
behavior in neurodegenerative conditions, especially bvFTD. Studies of the frontalsubcortical circuits contributed to explaining its phenomenological presentation. In
support of this view, and using the above definition, I hypothesized that three impaired
GDB mechanisms (initiation, planning, and motivation) contribute to subtypes of apathy.
The first subtype of apathy is related to an initiation difficulty. This subtype of apathy can
be seen in patients with disease in the ACC. The second subtype is due to impaired
planning, which results from disease in the dlPFC. The third subtype of apathy is related
to related to impaired goal selection and motivation that occurs when disease affects
areas in the OFC.
Research Design and Methods
Overview of research design. In Aim 1, structural MRIs in bvFTD participants
were compared to NC, and regression analyses related apathy scores (see Table 1) to grey
matter structures and associated white matter tracts. In Aim 2, results on a computerized
task, the PACT, were analyzed for apathy subtypes in bvFTD using the PACT measures,
and regional grey matter volume was then assessed for each impaired GDB component.
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In Aim 3, findings from Aims 1 and 2 were used to support the development of a research
proposal to examine mechanisms of longitudinal decline and neural compensation.
Table 1
Sample Criteria
Inclusion

Exclusion

Diagnosis of bvFTD (Rascovsky et al., 2011) or
NC.

Other neurologic conditions such as stroke or
hydrocephalus, primary psychiatric disorder such as
depression or psychosis, or systemic illness that
could interfere with cognitive functioning.

Mild disease stage (measured by Mini-Mental
State Exam ≥ 20).

Mini-Mental State Exam ≤ 19 to minimize
confounding factors related to cognitive impairment
by excluding persons with moderate or severe
dementia.

No depression as determined by Geriatric
Depression Scale Short Form score of ≤5.

Depressed patients (Geriatric Depression ScaleShort form score >5) since apathy is often clinically
confused with depression and could confound
interpretation of the data.

Modest doses of SSRI or antipsychotic medication
may have been needed for treatment as clinically
indicated, and, thus, were allowed. A stable dose
(no change in 3 months) was necessary to
minimize potential confound because these
medications can contribute to apathy (Benoit et
al., 2008).

Patients taking regular doses of benzodiazepines and
other soporific medications because of the sedating
effects of these drugs.

A reliable caregiver who had frequent contact with
the patient (>3 times/week for ≥1 hour).

Patients who do not have caregiver contact to ensure
accurate proxy ratings of the patient’s behavior,
since patients with bvFTD typically have poor
insight into their deficits (Eslinger et al., 2005).

Neuropsychiatric Inventory apathy subscale
frequency by severity score ≥1.

Captures bvFTD patients with higher likelihood of
having apathy syndrome.

Ability to speak and understand English language
sufficient to complete the questionnaires.

Patients with English language skills insufficient to
complete questionnaires.

Participants and setting. Participants with bvFTD and age- and educationmatched NC who were enrolled in the ongoing longitudinal study, “Cognitive and Neural
Impairment in Frontotemporal Dementia” (P01-AG17586) at the University of
Pennsylvania were selected for the proposed research. These participants had available
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neuropsychological, neuroimaging, and biomarker data. I focused particularly on bvFTD
because apathy is very common in this condition, these patients do not have physical
limitations that can confound the quantitative assessment of reduced GDB, and there are
no language or visuospatial deficits that can potentially limit the interpretation of bvFTD
patient performance. Participation was limited to those with apathy, determined by scores
on the NPI to increase the likelihood of capturing the phenomenon of interest.
Power Analysis. To conservatively estimate the power required to detect a
significant difference on the PACT between NC and bvFTD participants, I used the
PACT measure with the smallest difference between controls and bvFTD participants
found in our pilot data (Initiation score: bvFTD = 522ms ± 224.17 vs. NC = 375ms ±
69.46). With reasonable assumptions of 1.0 SD difference in performance between
groups and a beta of 0.8, a power analysis suggested that 18 participants were required in
each group to achieve a difference that is significant at the .05 level using Wilcoxon ranksum test. For the VBM imaging study, a minimum of 20 participants were required in
each group to detect a 1mm (equivalent to 1 voxel) change in grey matter at the p < .05
(corrected) level with a beta of 0.15 (power =. 85; Lerch & Evans, 2005; see Table 2).
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Table 2
Power Analysis
SD diff

β = 0.8

β = 0.9

0.5

68

91

0.75

31

41

1.0

18

24

1.5

9

12

2.0

6

8

Note. *Sample size needed to detect a mean difference between two groups from Wilcoxon rank-sum test;
alpha = .05.

Procedures. As previously described, this dissertation study was part of a larger,
ongoing longitudinal study entitled “Cognitive and Neural Impairment in Frontotemporal
Dementia” (P01-AG17586; PI: Virginia Lee, PhD, Clinical Core Leader: Murray
Grossman, MD). This study included individuals from the parent study who were
diagnosed with bvFTD and NC. University of Pennsylvania Institutional Review Board
(IRB) approval was initially obtained for P01-AG17586 in January 1999 and the most
recent continuing review approval from the IRB in September 2013 encompassed the
MRI procedures and the battery of neuropsychological testing that included the PACT.
I met with Dr. Grossman on a weekly basis to determine whether any newly
eligible patients had been entered into the abovementioned study. If so, the neurologist or
clinical coordinator asked the patient and caregiver if they were interested in hearing
more about the dissertation study. If so, I met the patient and caregiver to give an
overview and confirm their intention to participate.
Ideally, I would collect the PACT data, neuropsychological data and MRI data on
the same day. To maximize recruitment, retention, and convenience to participants, the
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patients and caregivers had the option to request that PACT and neuropsychological data
be collected during a follow-up in-home visit. In any case, I collected the MRI and PACT
data in the same 6-month period. Given the rate of brain volume change in bvFTD, 6
months is a widely accepted time frame in neuroscience research (Whitwell et al., 2008).
Data collection. I obtained the data for this study, including that generated from
the PACT, neuroimaging, and neuropsychological tests, from each participant in the
ongoing study (P01-AG17586). I administered the PACT which took approximately 45
minutes to complete. The neuroimaging sequence, completed by Department of
Radiology technicians, generally took 30 minutes to complete. The neuropsychological
tests were conducted by trained research technicians and took approximately 60 minutes
to complete.
I collected data in the Cognitive Neurology Clinic and in the Department of
Radiology at the Hospital of the University of Pennsylvania. I conducted the PACT and
neuropsychological tests in a quiet room in the Department of Neurology. Alternatively,
if the patient and caregiver desired, I collected the PACT and neuropsychological testing
during an in-home visit.
Instrumentation.
The Philadelphia Apathy Computerized Test (PACT). Experimental computer
tests examining the basis for a social behavior are useful in studying the mechanisms
contributing to the behavior. Moreover, they are quantitatively rigorous. The PACT was
intended to measure three components of GDB—initiation, planning, and motivation.
The PACT was developed based on a review of experimental paradigms in the scientific
literature and clinical observations (Elliott, Agnew, & Deakin, 2010; Jenkins, Jahanshahi,
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Jueptner, Passingham, & Brooks, 2000; Ruh, Cooper, & Mareschal, 2010). In all
experimental conditions, a trial began when the participant depressed a computer “start”
key with one finger. Reaction time (RT) to lift this finger from the start key in response to
a signal (RT1) and then RT to depress the target key once lifted from the start key (RT2)
were each measured. A practice block, in which participants received instructions about
task performance and 12 practice trials, preceded each of three experimental conditions
described below.
Initiation refers to one’s ability to self-generate or activate actions (Levy &
Dubois, 2006). In the simplest condition designed to measure initiation, the participant
began a trial by depressing the start key; a central stimulus appeared on the computer
screen, and a fixed central target key was then depressed in response to this stimulus;
over 48 trials, the signal occurred on average 1,250msec (range 500–5000msec) after
depressing the start key. Initiation was assessed by RT1 in this condition.
Planning refers to the ability to elaborate plans of action (Levy & Dubois, 2006).
Thus, assessing the planning component required a resource-demanding task that
depended on the integration of strategies to meet the challenges of the condition (Sorel &
Pennequin, 2008; Toglia & Berg, 2013). In the second condition, designed to assess the
planning component of GDB, two levels of task difficulty were assessed. In the first level
(simple planning), after depressing the start key, participants were signaled by randomly
ordered lateralized visual stimuli to press a left or right target key (stimulus appears on
left, then go left; stimulus appears on right, then go right). In the second, more complex
level, one of two lateralized keys is pressed contingent on the combination of patterns in
a central visual stimulus (if the stimulus is blue or has horizontal stripes, the key on the
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left is correct; if the stimulus is orange or contains vertical stripes, the key on the right is
correct). To assure that planning could be assessed specifically, we minimized the
influence of working memory confounds by making the patterns visually available to
participants during performance. We assessed two measures of planning: total latency in
the complex planning condition and the difference in response times between the two
levels of difficulty.
Motivation refers to the ability to associate affective signals (positive or negative)
with value in order to perform actions (Levy & Dubois, 2006). In the third condition,
designed to assess motivation, the simple condition was repeated with an explicit
monetary incentive using a point system (monetary units) to reward participants for
responding correctly and more rapidly. Participants received feedback on the computer
screen about their response speed after each trial. Sensitivity to negative consequence
was assessed by having a “penalty” condition. In this “penalty” condition, we gave
participants a number of monetary units at the beginning of each task, and took away
monetary units if they did not respond correctly and more rapidly. I used the penalty
condition measure to assess motivation because previous work has shown that bvFTD
patients are particularly insensitive to negative feedback (Grossman et al., 2010). I used a
point system involving “monetary units” and monetary units were “converted” to actual
money in a manner that allowed all participants to receive the same total payment at the
end of the study.
I obtained 48 experimental trials during each condition. I measured RT1, RT2,
total latency (RT1 + RT2) and errors. Average RTs for initiation, planning, and
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motivation (see Table 3) were each generated from the conditions described above and
used in the regression analyses (Aim 1).
Table 3
Scores Generated From the PACT
Score

Measure

Initiation score

Average Reaction Time 1 in simple condition

Planning score

Average total latency in complex planning condition

Motivation score

Average total latency in simple penalty condition

Structural MRI. I obtained MRI data with the support of P01-AG17586 (PI:
Virginia Lee, PhD; Clinical Core Leader: Murray Grossman, MD). Three-dimensional
T1-weighted structural MRI provided 1 mm3 resolution for assessing grey matter-volume
loss, and we used spoiled gradient-echo imaging (MPRAGE on our Siemens Trio) with
an inversion preparation to increase grey/white matter contrast at high field. We used
three dimensional spoiled gradient echo imaging parameters as follows: TR = 1620ms,
TI = 950ms, TE = 3ms, flip angle = 15°, 160 contiguous slices 1.0 mm thick, in-plane
resolution 0.9×0.9 mm, FOV = 192x256mm2, matrix = 192 X 256, 1NEX with a total
scan time of 6 min for the entire volume. We repeated this sequence twice, allowing
signal-to-noise ratio to be increased by signal averaging following realignment, or one
volume could be discarded if excessive motion (> 3mm in any axis) occurred. We
acquired diffusion-weighted images (DWI) using a single-shot, spin-echo, diffusionweighted echo planar imaging sequence (FOV = 245mm; matrix size = 128 × 128;
number of slices = 57; voxel size = 2.2mm isotropic; TR = 6,700ms; TE = 85ms; fat
saturation). In total, we acquired 31 volumes along 30 noncollinear directions per subject,
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one without diffusion weighting (b = 0 s/mm2) and 30 with diffusion weighting
(b = 1,000 s/mm2).
Neuropsychological tests. Researchers collected neuropsychological data shown
in Table 4 for the parent study and made them available to me. Researchers use
neuropsychology test results to help to improve characterization of apathy in bvFTD,
because preliminary data associate apathy with executive and social deficits (Chow et al.,
2009; Eslinger et al., 2011; Eslinger et al., 2012; Eslinger et al., 2007; Girardi,
Macpherson, & Abrahams, 2011). The overall guiding principle for the parent study was
that the neuropsychological battery was comprehensive in its scope, and included
measures with good psychometric properties that were well normed for a broad age range,
yet administrable in a reasonable amount of time (in our experience, about 60 minutes). I
used two of the available measures to execute the inclusion/exclusion criteria, and,
although no measures specific to components of GDB (initiation, planning, and
motivation) were included in the database, several tests or items sampled some aspects of
these components, thereby potentially providing auxiliary support for the PACT.
Data management. I managed data using web-based, intranet data management.
The database server was Microsoft SQL Server 2005 with front end application
developed in PHP dynamic web language, hosted via Microsoft IIS 6.0 web server. The
database, located on the University of Pennsylvania Health System (UPHS) network, was
protected from the Internet via the UPHSnet firewall. The servers were part of the UPHS
enterprise backup system. Backups were performed daily by the UPHS backup
administrators. MRI data were archived onto compact disk (CD) from the scanner
immediately following data acquisition. Data were loaded onto a workstation, stripped of
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identifying information, and transferred via secure ftp to a specific account for this
project on the Center for Functional Neuroimaging (CfN) web server at the University of
Pennsylvania. Data stored on the CfN cluster were backed up weekly using SDLT tape,
and daily interim backups were performed onto external firewire hard drives. All data
entered were cleaned, transformed and analyzed using the statistical software package
SPSS 21.0 for Mac.
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Table 4
Neuropsychological Data
Name of test

Time

Brief description

Mini-Mental State 10 minutes A screen for dementia. Determines cognitive
Exam (Folstein,
impairment using a cutoff of 23. The instrument has a
Folstein, &
sensitivity of 82% and specificity of 99% for
McHugh, 1975)
determining cognitive impairment with this cutoff
(Tangalos et al., 1996).

Use in study
Mini-Mental State
Exam assessed
severity of cognitive
dysfunction to
determine
inclusion/exclusion.

10 minutes Measures depression briefly in elderly and in persons Identified depressed
Geriatric
Depression Scale
with dementia where a longer form may be burdensome patients who were
Short Form (Sheikh
(Burke, Roccaforte, & Wengel, 1991; Lach, Chang, & then excluded from
& Yesavage, 1980)
Edwards, 2010). This instrument has sensitivity and
the study.
specificity of 87% and 83% respectively. The Geriatric
Depression Scale was chosen because it ascertains
affective symptom ratings of depression.
Neuropsychiatric 15 minutes Evaluates 12 neuropsychiatric disturbances, including Confirmed caregiverInventory
apathy, as rated by caregivers, each with a frequency by perceived presence of
(Cummings, 1994)
severity score. Content validity, concurrent validity,
apathy for inclusion in
interrater reliability and test–retest reliability of the
the study, and
Neuropsychiatric Inventory were established by past measured associated
work (Cummings et al.,1994).
caregiver distress.
Apathy Evaluation 10 minutes An 18-item caregiver-completed scale that is
Assessed caregivers’
Scale-Informant
commonly used to quantify global apathy. Responses to perceptions of the
Rated (AES-I)
items were recorded on a 4-point Likert-type scale with patient’s level of
(Marin, Biedrzycki,
the following categories: Not at All True, Slightly True, motivation.
& Firinciogullari,
Somewhat True, and Very True. A higher score
1991)
represents greater apathy severity.
Response to the single item, “He/she has motivation,”
was used to determine the subject’s level of motivation.
Digit Span
Backward

3 minutes Digits are repeated in the reverse. Assesses mental
manipulation and planning.

Assessed planning.

Trail Making

5 minutes An alternating pattern is traced between numbers and
letters.

Assessed planning.

Letter Guided
Fluency

5 minutes Name words beginning with the letters F, A, and S in
60 seconds each; first quartile fluency assesses
initiation (Lamar, Zonderman, & Resnick, 2002).

Assessed planning,
initiation.

Overall plan for analysis. I described the overall sample demographically and
according to continuous measures of the PACT and relevant scores on the
neuropsychiatric measures using means, standard deviations, and interquartile ranges. For
categorical data, I used frequencies and percentages.
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Analysis Aim 1.
Grey matter imaging. I used VBM to quantify significant grey matter changes in
the bvFTD sample acquired with high resolution volumetric T1 MPRAGE images. All
images were preprocessed using PipeDream (Sourceforge, 2014) and advanced
normalization tools (ANTS, Penn Image Computing Science Lab, 2014) to perform the
most stable and reliable multivariate normalization and structure-specific processing
currently available (Avants, Epstein, Grossman, & Gee, 2008). PipeDream deforms each
individual dataset into a standard local template space in a canonical stereotactic
coordinate system. Core processing involved mapping T1 structural MRI to a populationspecific template consisting of an unbiased average-shape and average-appearance image
derived from a representative population of 25 healthy seniors and 25 patients with FTD
(J. Kim et al., 2008). This procedure provided superior representations of variable
anatomy as occurs in distinct populations such as in the examination of a healthy
population and those with a neurodegenerative condition (Avants & Gee, 2004). I used a
diffeomorphic deformation for registration that is symmetric so that it is not biased
toward the reference space (for computing the mappings) and preserves topology to
capture the large deformation necessary to aggregate images in a common space. These
algorithms allowed template-based priors to guide cortical segmentation and compute
grey matter atrophy (Das, Avants, Grossman, & Gee, 2009). We used SPM8 to smooth
images using a 4mmFWHM Gaussian kernel and to compare patients to matched controls
using a two-sample t-test. We accepted clusters containing a peak voxel that survived a
p < .001 (FDR-corrected) height threshold and a 50 adjacent-voxel extent. We then used
the regression module in SPM8 to identify the relationship between performance on each
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PACT score (see Table 3) and grey matter density. To constrain the interpretation of the
regression analysis to areas of known disease in participants, we used an atrophy mask
generated from the t-test contrasts of bvFTD relative to NC. For each regression, we
entered a single PACT score (average RTs over 48 trials) for each condition (see Table 3)
for each patient. For the regression analyses, we accepted that a cluster was related to
behavior if it contained a peak voxel which survived a p < .005 height threshold and a 30
adjacent-voxel extent.
White matter imaging. DWIs were preprocessed with PipeDream and ANTS, as
above. We removed motion and distortion artifacts by affine coregistration of each DWI
to the unweighted (b = 0) image. We computed DTs using a linear least squares algorithm
(Salvador, Suckling, Schwarzbauer, & Bullmore, 2005) implemented in Camino (Cook et
al., 2006), and tensors were reoriented using the preservation of principal directions
algorithm (D. C. Alexander, Pierpaoli, Basser, & Gee, 2001). We computed fractional
anisotropy (FA) from the DT image for each subject and corrected distortion between T1
and DT images by registering the FA image to the T1 image. We warped each
participant’s T1 image to the template via the symmetric diffeomorphic procedure in
ANTS; then warped the FA image to template space by applying the T1-to-template
warps.
We smoothed FA images using a 4mm full width at half maximum (FWHM)
isotropic Gaussian kernel. I performed DTI analyses of FA in SPM8 using the twosamples t-test module and analyzed DTI volumes using an explicit mask (FA ≥ 0.25) to
constrain comparisons to regions of white matter. Comparisons of bvFTD participants to
matched controls used a p < .005 (false discovery rate [FDR]-corrected) height threshold
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and a 200-voxel extent. I constrained regression analyses to white matter tracts with
reduced FA using an explicit mask generated from the results of the direct comparison
with NC. Using a deterministic tractography procedure in Camino (Cook et al., 2006), I
tracked white matter fibers in a healthy-subject template generated using the DTI
sequence described above. I retained fiber tracts that passed through voxels of reduced
FA to define the mask for regression analyses. I accepted a significant cluster with a
volume of 150 adjacent voxels and a peak voxel Z-score > 3.3 (equivalent to p < .0005).
Analysis Aim 2.
Behavioral data. I described the sample according to the proposed apathetic
subtype of initiation, planning, and motivation (see Table 5) using means, standard
deviations, and z-scores. Shapiro–Wilks tests were used to assess normality in the data. I
examined differences on scores on each task (initiation score, planning score, and
motivation score) between bvFTD and NC groups using independent samples t-tests.
Because the data were not normally distributed, I assessed differences between subject
groups using nonparametric tests such as the Mann–Whitney U statistic. I calculated
correlations with neuropsychiatric tests (see Table 4) using Spearman’s rho. I expected
initiation measures to be significantly associated with first quartile letter-guided fluency.
I expected planning measures would be significantly associated with performance in the
overall score on the digit span backward, trail making, and letter-guided fluency. Last, I
expected a significant association between motivation measures and score (1–4) on the
single AES-I item, “He/she has motivation.”
I hypothesized specific apathy profiles as well, and described the number of
participants in each subtype according to predetermined criteria (see Table 5). I generated
	
  

34
individual z-scores relative to NC. I designated participants as a specific subtype if the zscore was ≥ 2.0 for one profile criteria, but within the range of normal (i.e., z-score ≤ 2.0,
p ≤ .05) for the remainder of the tasks.
Table 5
Behavioral Criteria for Apathy Subtypes
Subtype profile

Criteria

Initiation

Significantly slow Reaction Time 1 in simple condition
Does not have slowed latencies for complex condition
Able to improve performance on the simple condition in response to penalty

Planning

Significantly slowed on complex planning condition and, for those with multiple
impairments, significant slowing on the complex planning condition compared to the
simpler planning condition
Does not have slowed initiation for simple condition
Able to improve performance on the simpler planning condition in response to penalty

Motivation

Significantly slowed on simple penalty condition and fails to improve performance
with penalizing motivators
Does not have slowed initiation for simple condition
Does not have slowed latencies for complex condition

Grey matter imaging. I obtained a priori defined regions of interest (ROI) for
ACC, dlPFC, and OFC. I selected these ROIs based on literature suggesting that poor
initiation is related to disease in ACC (Kotchoubey et al., 2003; Reijnders et al., 2010),
poor executive function is related to disease in dlPFC (Kaller et al., 2011; Unterrainer,
Rahm, Kaller, Leonhart, et al., 2004; van den Heuvel et al., 2005) and reduced motivation
is related to disease in OFC (Diekhof, Falkai, & Gruber, 2011; Sescousse, Redoute, &
Dreher, 2010). I used the standardized automated anatomical labeling (AAL) and
parcellation method (Tzourio-Mazoyer et al., 2002) to label the following ROIs. The first
ROI (e.g., initiation) was centered on the ACC (AAL label = ACIN). The second (e.g.,
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planning) ROI was centered on the middle frontal gyrus portion of the dlPFC (AAL label
= F2). The last ROI (e.g., motivation) was composed of the orbital regions of the middle
and superior frontal gyri (AAL labels = F10, F20). Additionally, I assigned a control ROI
in the midtemporal (MT) region (AAL label = T2). I chose this region because it is an
area implicated in bvFTD (Brettschneider et al., 2014), but is not hypothesized to
contribute to GDB. For all ROIs, I computed the mean grey matter probability (GMP)
value, divided by the subject’s individual average whole-brain GMP value. I used this
ratio to examine relative differences in regional composition of grey matter in frontal
areas thought to underlie GDB impairments and the control region in the lateral temporal
lobe.
Anticipated Study Difficulties and Alternative Approaches Used to Achieve
Aims.
Prior to initiating this study, I anticipated potential difficulties and identified
alternative approaches to achieve the aims:
Interpretation and potential problems, Aim 1. I predicted that apathetic bvFTD
participants would have significant atrophy in the frontal lobe. Further, PACT initiation
scores would be related to significant ACC atrophy and associated white matter tracts;
PACT planning scores would be related to atrophy in dlPFC and associated white matter
tracts, and PACT motivation scores would be related to atrophy in OFC and associated
white matter tracts. These predictions were made based on the literature suggesting that
poor initiation is related to ACC disease (Kotchoubey et al., 2003; Reijnders et al., 2010),
poor executive function is related to disease in dlPFC (Kaller et al., 2011; Unterrainer,
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Rahm, Kaller, Ruff, et al., 2004), and reduced motivation is related to disease in OFC
(Diekhof et al., 2011; Sescousse et al., 2010).
Anticipating that the regression analyses might not detect a distinct relationship
between grey matter density and behavioral performance, I planned to use cortical
thinning rather than grey matter density. It was possible I would find atrophy related to
the striatum, given the observation of apathy in Parkinson’s patients with striatal disease
(Drapier et al., 2006), strong frontal-striatal connections (Bonelli & Cummings, 2007)
and the observation of histopathological disease in the striatum of bvFTD (Seelaar,
Rohrer, Pijnenburg, Fox, & van Swieten, 2011; Whitwell et al., 2009). Anticipating the
possibility that participants with long disease duration would have diffuse, nonspecific
atrophy, I examined only participants with mild cognitive impairment. I expected some
difficulty obtaining imaging in some participants because of time restriction, medical
contraindication (e.g., claustrophobia or pacemakers) and participant preferences. If that
were the case, I still planned to ask subjects to participate in the PACT assessment, using
t-tests to confirm no significant differences between those with and without imaging data.
Interpretation and potential problems, Aim 2. I expected differences in PACT
scores between bvFTD and NC groups. I predicted each apathetic subtype would show a
distinct performance profile on the PACT. The initiation subtype would have slow RT1
across all conditions in the PACT. Once initiated, tasks would be performed slowly
(RT2) but accurately. Participants would not have slowed latencies for complex
conditions and would be able to improve their total latency times in response to
incentives. The planning subtype would have significantly slow total latency on the
complex planning condition, but participants would not have significantly slowed
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initiation. They would also improve their time in response to incentive. The motivational
subtype would improve less in response (measured by total latency) to financial
incentive—and particularly the penalty condition—than the initiation and planning
patients under the simpler planning condition, but would not have slowed initiation times,
and would not have disproportionally slowed performance for the complex planning
condition. This insensitivity to penalty is supported by previous studies that show bvFTD
patients are insensitive to negative consequences but respond to a reward (Farag et al.,
2010; Grossman et al., 2010; Torralva, Roca, Gleichgerrcht, Bekinschtein, & Manes,
2009).
I acknowledged that my data might not support clear distinctions between the
apathy subtypes; in this case, I planned to adjust my subtype criteria, which might include
more stringent inclusion criteria for one or more of the subtypes.
Human subjects.
Human subjects involvement and characteristics. This dissertation study was
part of a larger ongoing longitudinal study entitled “Cognitive and Neural Impairment in
Frontotemporal Dementia” (P01-AG17586; PI: Virginia Lee, PhD, Clinical Core Leader:
Murray Grossman, MD). For the purpose of this study, we offered participation to
subjects diagnosed with bvFTD and NC. See Table 1 for a description of inclusion and
exclusion criteria. I selected a total sample of 37 subjects (20 bvFTD and 17 NC).
Primary study approval. University of Pennsylvania IRB approval was initially
obtained for P01-AG17586 in January 1999 from the University of Pennsylvania. Most
recently (September 2013), the University of Pennsylvania IRB awarded the P01
continuing approval for a protocol that included neuropsychological testing including the
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PACT, questionnaires, and MRI procedures. For the dissertation study, I obtained IRB
approval to amend the parent study (P01-AG17586) to include the above analyses on July
25, 2012.
Source of materials. I obtained the materials for this study, including data
generated from the PACT, neuroimaging, and neuropsychological tests (including the
NPI), from participants in the parent study. The PACT took approximately 45 minutes to
complete. The neuroimaging sequence generally took 30 minutes to complete. The
neuropsychological tests took approximately 60 minutes to complete.
I collected data in the Cognitive Neurology Clinic and in the Department of
Radiology at the Hospital of the University of Pennsylvania. If the subject and caregiver
desired, I collected the PACT and neuropsychological testing during an in-home visit. I
entered the raw data, which included subject and caregiver demographics, directly into a
Web-based data-management system. I anonymized data through the use of alpha
numeric identification numbers, and kept the key for the identification in a separate
password-protected site. The server was log-in accessible only to the investigators and
key study personnel. Data and all analyses for this study were kept on this server. After
the data were entered, I stored the raw data in the Department of Neurology in a secured
file cabinet and will keep it for 6 years to satisfy university policy.
I archived all MRI data from the scanner onto compact disk immediately
following data acquisition. I loaded data onto a workstation, stripped them of identifying
information, and transferred them via secure ftp to a specific account for this project on
the CfN web server at the University of Pennsylvania. I backed up data stored on the CfN
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cluster weekly using SDLT tape, and made daily interim backups onto external firewire
hard drives.
Potential risks and adequacy of protection against risks.
Informed consent and assent. Informed consent and assent for the parent study
were obtained from the caregiver and patient in accordance with the University of
Pennsylvania IRB approved procedures. Participants were recruited from a pool of
patients and their caregivers in the Cognitive Neurology Clinic at the Hospital of the
University of Pennsylvania. After participants were evaluated for inclusion/exclusion by
a cognitive neurologist (MG), they were provided a written and verbal explanation of the
purpose, protocol, risks, and benefits of the study. At all times during the informedconsent process, potential study participants were reminded that participation was
voluntary and withdrawal was an acceptable alternative to participation. After
participants/caregivers had an opportunity to ask questions, fully informed written/assent
was obtained from patient and caregiver.
Assessing each individual’s capacity was an important step in the informedconsent process, because cognitively impaired individuals, such as those with bvFTD,
may not have been able to understand relevant information or may not have been able to
reason about the alternatives available to them. Previous research has shown that ND
patients with preserved awareness of their diagnosis, symptoms, and prognosis are likely
to retain the capacity to make decisions about their care (Karlawish, 2008). Because
judgment and insight are lost early in bvFTD patients (Piguet, Hornberger, Mioshi, &
Hodges, 2011), we did not assume capacity to consent even with “mildly impaired”
scores on the MMSE. To our knowledge, no studies addressed the decision-making
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capacity of bvFTD patients. Capacity assessment remains a clinical assessment
performed by the cognitive neurologist (MG). If patients did not have sufficient capacity
to consent, then assent was obtained. At minimum, assent from the patient and proxy
consent were obtained for all participants. Potential risks for patients and caregivers who
participated in this study were related to subject burden and distress as well as
administration of testing materials. A list of the potential risks in this study and the
protections against risks are addressed below.
Risk associated with PACT and/or neuropsychological testing for patients.
Patients took no physical risks by performing the PACT and answering questions
associated with the neuropsychological tests. Some participants may have become
fatigued or felt anxious while performing these tests.
Protection against risk. The testing was divided into several small sections,
thereby providing frequent rest periods, and the testing may have continued during a
follow-up session, as appropriate. Participants could request additional rest periods at any
time. Prior to each task, we discussed the nature of the task. Because participation in the
study was voluntary, participants could choose not to answer any question and had the
right to withdraw if desired.
Risks associated with MRI. There is little risk associated with MRI studies. Many
participants have been safely studied in MRI research. The technique uses no radiation,
so it can be repeated with no known adverse effects (Cogbill & Ziegelbein, 2011). The
measurement is painless, but it is noisy inside the magnet. The magnetic field is not
harmful in itself, but implanted devices (e.g., pacemaker) that contain metal may
malfunction during the MRI. In addition, a metallic object may fly through the air toward
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the magnet and hit the patient. Last, participants may experience claustrophobia in the
machine; thus, we excluded participants with a known history of claustrophobia from the
MRI portion of the study.
Protection against risk. We gave participants earplugs to decrease the noise level
while in the scanner. Because of the strong magnetic field, we excluded patients with
pacemakers or other metallic implants from this component of the study. Participants and
caregivers completed an MRI screening form with study personnel before entering the
MRI room. The purpose of the form was to identify known metallic implants that would
be a contraindication for MRI. We required participants to remove all metal from their
person and clothing, including metal objects in their pockets before entering the MRI
room. Last, we gave participants a call bell to squeeze if they became uncomfortable or
claustrophobic, and the MRI study was stopped at that point.
Risks associated with caregiver questionnaires. We held some concern for
psychological distress for the family caregivers when we administered the NPI and AES-I.
Neuropsychiatric features in dementia can be a sensitive topic and some caregivers were
at risk for becoming upset. Similar research studies involving interviews with spousal
caregivers, however, found that the experience afforded them a positive opportunity to
share their experience and contribute to scientific knowledge (Hellstrom, Nolan,
Nordenfelt, & Lundh, 2007; Mastwyk, Ritchie, LoGiudice, Sullivan, & Macfarlane,
2002).
Protection against risk. In the event that a negative emotional response occurred,
we reminded caregivers that they did not have to answer any question with which they
felt uncomfortable and they were provided a break. Additionally, we provided caregivers
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with support-group information. The name and contact information for a licensed
psychologist who has experience working with caregivers of persons with dementia was
also available.
Ethics of participant payment. We paid participants $35 for the burden
associated with the MRI procedure of the parent study. Also, we paid participants an
additional $10 for participating in the PACT. This test asked participants to make
decisions about picture stimuli on a computer screen. The experimental hypothesis tested
whether participants were able to improve their times in return for positive feedback. In
the PACT, points were awarded for appropriate responses or deducted for inappropriate
responses. We told all participants that the number of points they accumulated would be
converted into a monetary award at the end of the experiment. We constructed a
conversion scale so that we paid all participants $10 for their participation, regardless of
the points they earned. To calculate reimbursement, we used the wage-payment model.
This payment model operates on the notion that research participation requires little skill,
but does require time and effort (Dickert & Grady, 1999). We chose this model because it
standardizes the payment process so that all participants were paid equally.
Potential benefits of the proposed research to human subjects and others. We
informed participants that they would have no additional risk and receive no additional
benefits from analysis of data in this study. It is possible that although these results may
benefit patients and caregivers in the future, participants in this study would not realize
an immediate or direct benefit from participating. Given the minimal risks associated
with this study, and the general benefits to the patients and families with ND and the
research community, the overall risk-to-benefit ratio was favorable. Further, we found
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research studies that suggested there are altruistic benefits to participating in dementia
research, even if the subject is not directly benefited (Law, Russ, & Connelly, 2013;
Lynoe, Sandlund, & Jacobsson, 1998).
Importance of knowledge to be gained. The overall goal of this innovative
research project was to identify the neural mechanisms that contribute to apathy in
patients with a certain type of ND. By identifying three distinct impairments in GDB,
interventions can be explored based on an individual’s pathology profile. Interventions
may help the apathetic patient engage in activity, but the interventions must be tailored to
the subtype of apathy. To facilitate this research, researchers need an objective evaluation
that is able to differentiate subtypes of apathy by neuroanatomical mechanisms. Then a
systematic evaluation of existing interventions for apathy will be warranted, followed by
the testing of interventions designed by apathetic subtype. These studies are necessary to
improve patient and caregiver quality of life.
Inclusion of women and minorities. The sample included both male and female
adults. FTD affects slightly more men than women (Johnson et al., 2005), and to date, the
parent study tended to recruit slightly more male than female patients. In the case of an
imbalanced enrollment, I planned to query the database to find a representative sample.
Recruitment, selection, and enrollment were not discriminatory regarding race or
gender; however, an unequal number of minorities were enrolled in the parent study.
Recent research suggested that members of minority populations are less likely to
participate in dementia research because, relative to their Caucasian counterparts, they
are often diagnosed later, and thus do not receive specialized dementia care (Cooper,
Tandy, Balamurali, & Livingston, 2010). Ongoing efforts to engage a community of
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minorities included a monthly educational series at community centers in Philadelphia
and surrounding areas. Researchers used these efforts to aggressively increase and retain
minority-group representation.
Inclusion of children. The participants in this study were adults age 21 and older.
We excluded children, as this research relates to adults with ND.
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Abstract
Apathy, the major manifestation of impaired GDB, is the most common neuropsychiatric
syndrome associated with bvFTD. The behavioral and biological mechanisms of apathy,
however, are not well understood. To improve understanding of apathy, we examined the
neural basis of GDB in bvFTD. Eighteen apathetic bvFTD participants and 17 healthy
controls completed the PACT. This test quantifies each of three components of GDB—
initiation, planning, and motivation—hypothesized to contribute to apathy. We then
analyzed the association between PACT scores with grey matter atrophy and reduced
white matter FA in bvFTD. Compared to controls, bvFTD participants demonstrated
significant impairments in the three hypothesized components of GDB that contribute to
apathy. Regression analyses related each component to disease in specific grey matter
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structures and associated white matter tracts. Poor initiation related to grey matter
atrophy in anterior cingulate and reduced FA in cingulum. Planning impairment related to
grey matter atrophy in dlPFC and reduced FA in superior longitudinal fasciculus. Poor
motivation related to grey matter atrophy in orbitofrontal cortex and reduced FA in
uncinate fasciculus. bvFTD patients have difficulty with initiation, planning, and
motivation components of GDB. These findings are consistent with the hypotheses that
GDB encompasses three processes, that these are supported by a large-scale neural
network in specific portions of the frontal lobe, and that degradation of any one of these
prefrontal regions in bvFTD may contribute to apathy.
Introduction
Apathy is among the most common behavioral manifestations that contribute to
bvFTD (Diehl-Schmid et al., 2006). However, the mechanisms that contribute to apathy
are poorly characterized. We hypothesize that apathy can be operationalized as an
impairment in GDB that is essential to daily human functioning. GDB defined as “broad
spectrum of purposeful actions, from the simplest movement to the most complex
patterns of behavior” (Brown & Pluck, 2000, p. 416)—includes mechanisms such as
initiation, planning, and motivation, which allow a person to direct purposeful behavior
toward a desirable goal or away from an undesirable outcome (Geurts & de Wit, 2013).
In this study, we examined dissociable behavioral and neuroanatomic components of
GDB in bvFTD in an effort to improve understanding of apathetic behavior.
Most studies of bvFTD assumed that apathy is a single, undifferentiated
behavioral phenomenon. Using a unitary model, researchers have linked apathy in
bvFTD to several prefrontal areas, including dorsolateral, anterior cingulate, and orbital
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regions (Massimo et al., 2009; Zamboni et al., 2008). Heterogeneous findings such as
these may reflect that apathy is multifactorial, consistent with the GDB model, and that
each of these anatomic regions supports one component of a large-scale network that may
be compromised in bvFTD patients who display apathy. In the present study, we used a
novel RT test that directly ascertains each of three components thought to play a role in
GDB, and we relate patterns of impairment for each component to MRI regions of grey
matter atrophy and white matter integrity in bvFTD.
Methods
Participants. Eighteen bvFTD patients (five women) were recruited from the
outpatient clinic of the Department of Neurology, University of Pennsylvania and
evaluated by experienced cognitive neurologists (DJI, MG) using published consensus
criteria (Rascovsky et al., 2011). All patients had mild disease (MMSE ≥ 20) to minimize
potential confounding factors related to severe cognitive impairment. Medical and
psychiatric causes of dementia were excluded by clinical examination and blood- and
brain-imaging tests. We also excluded individuals with depression using the Geriatric
Depression Scale-Short Form (Sheikh & Yesavage, 1980) scores > 5, as depression can
be confused with apathy, and we excluded participants taking benzodiazepines and other
soporific medications because of their sedating side effects. All participants had apathy,
determined by the NPI (Cummings et al., 1994) FxS score >1. The FxS score is rated on
the basis of scripted questions administered to the patient’s caregiver, yielding a
maximum score of 12. Caregiver also rate their own levels of distress for each domain.
Seventeen healthy seniors served as a control group for the behavioral measure. Control
participants were demographically-comparable to bvFTD participants for age and
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education and self-reported a negative neurological or psychiatric history. See Table 6 for
a summary of demographic characteristics. All participants and responsible caregivers for
patients participated in an informed-consent procedure approved by the University of
Pennsylvania IRB.
Table 6
Mean (+S.D.) Demographic and Clinical Features of Patients with Behavioral Variant
Frontotemporal Degeneration and Healthy Controls
Controls (n = 17)

bvFTD (n = 18)

Age (Years)

67.12±10.82

61.00± 5.2

Education (Years)

15.35±2.91

17.00± 3.1

Disease duration (Years)

na

3.70±1.63

Mini-Mental State Exam
(max score=30)

29.47±0.87

27.33±2 .2

Behavioral measures.
The Philadelphia Apathy Computerized Test (PACT). The PACT was developed
to quantify components of GDB that are compromised in patients with apathy. It was
developed based on a review of experimental paradigms in the literature and clinical
observations of apathy (Jenkins et al., 2000; Ruh et al., 2010). Briefly, a computerized
RT was obtained to assess initiation, planning, and motivation components of GDB.
Participants had a brief practice period of several trials for each of the measures described
below, and all participants appeared to understand the tasks.
To assess the initiation component, participants began a trial by depressing the
“start” key, then a central visual stimulus (triangle) appeared on the computer screen
(latency ranging pseudorandomly 500–1,200msec); finally, another fixed central target
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key must be depressed in response to this stimulus for 48 trials. To obtain an initiation
score, we measured the latency for the subject to lift the finger off of the start key in
response to the stimulus on the screen.
Assessing the planning component required a resource-demanding task that
depended on the integration of strategies to meet the challenges of the condition (Sorel &
Pennequin, 2008; Toglia & Berg, 2013). Here, participants must correctly press one of
two pseudorandomly lateralized keys, contingent on the combination of two features of a
central visual-pattern stimulus: if the stimulus is blue or has horizontal stripes, the key on
the left is correct; if the stimulus is orange or contains vertical stripes, the key on the right
is correct. To assure that planning could be assessed specifically, we minimized the
influence of working memory confounds by making the patterns visually available to
participants during performance. A planning score was generated by averaging the total
latencies on correct trials of the planning task described above.
To assess the motivation component, the participant performed the initiation task
described above; here, we gave participants an additional amount of money in the form of
monetary units at the beginning of the task, and money was taken away as a “penalty” if
they did not respond more rapidly to a stimulus relative to their previous performance,
obtained during the initiation task described above. Participants received verbal and
visual feedback (a bank of points appeared on the screen) about their response speed after
each trial on the computer screen, compared to their prior RT, and we told participants
that monetary units would be converted to money at the end of the study. Participants
also performed a “reward” condition where they receive points for responding more
rapidly than during the initiation condition (reward and penalty conditions were
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administered in a randomly ordered manner across participants, but we used the penalty
condition to obtain a motivation score because previous work has shown that bvFTD
patients are particularly insensitive to negative feedback (Grossman et al., 2010).
Neuroimaging data. Structural MRI data were available for all bvFTD
participants with PACT scores (n = 18), and DTI data from the same scan session were
also available for a subset of these participants (n = 15). We acquired high-resolution T1weighted 3-dimensional spoiled gradient echo images on a Siemens 3.0T Trio scanner
with an 8-channel coil (repetition time = 1,620msec, echo time = 3msec, slice thickness =
1.0mm, flip angle = 15°, matrix = 192 × 256, and in-plane resolution = 0.9 × 0.9mm). We
acquired DWI using a single-shot, spin-echo, diffusion-weighted echo planar imaging
sequence (FOV = 245mm; matrix size = 128 × 128; number of slices = 57; voxel size =
2.2mm isotropic; TR = 6,700ms; TE = 85ms; fat saturation). In total, we acquired 31
volumes per subject, one without diffusion weighting (b = 0 s/mm2) and 30 with diffusion
weighting (b = 1,000 s/mm2) along 30 noncollinear directions. For comparison, we
selected a standardized sample of 24 controls with existing MRI and DTI. Two sample
t-tests confirmed that patients and controls [mean age = 60.71 years (SD = 6.9); mean
education = 15.79 years (SD = 1.9)] were demographically comparable (age, education,
and gender, all p > .1). To ensure our imaging control cohort was representative of the
behavioral control cohort, we performed two-sample t-tests and confirmed that these
groups were demographically comparable (age, education, and gender, all p > .1).
Grey matter imaging data. Before normalization, we segmented each individual’s
structural image into tissue classes using Atropos, a voxel-based segmentation tool that
segments the brain into grey matter, white matter, and cerebrospinal fluid (Avants,
	
  

51
Tustison, Wu, Cook, & Gee, 2011). We preprocessed all images using PipeDream
(Sourceforge, 2014) and ANTS (Penn Image Computing & Science Lab. 2014) to
perform multivariate normalization. Researchers demonstrated that this method
accurately normalizes large-scale data in studies of patients with ND (Avants et al., 2008;
Avants, Tustison, Song, et al., 2011). We used a diffeomorphic deformation for
registration that is symmetric so it is not biased toward the reference space for computing
the mappings (Avants, Tustison, Song, et al., 2011). Processing involved mapping T1
structural MRI to an unbiased average-shape and average-appearance template derived
from a representative population consisting of 25 healthy seniors and 25 patients with
FTD (J. Kim et al., 2008) This diffeomorphic method for registration and normalization
avoids the need to use identical participants in the local template. Grey matter probability
images were calculated as a quantitative measure of grey matter density. We then
transformed grey matter probability images into Montreal Neurological Institute space for
statistical analysis and down-sampled to 2mm3 resolution to attain a more anatomically
relevant voxel size.
We used SPM8 (SPM, 2014) to smooth grey matter images using a 5mmFWHM
Gaussian kernel. We conducted a whole-brain analysis: First, we compared grey matter
density in bvFTD and 24 healthy seniors using a two-sample t-test with a voxel level
threshold of p < .001 (FDR-corrected) and extent threshold of 50 voxels. In the second
analysis, we performed regressions to relate grey matter density in bvFTD directly to the
scores (initiation, planning, and motivation) on the PACT. We restricted regression
analyses to evaluate only potential relationships between PACT performance and regions
demonstrated to be atrophied in our bvFTD sample in an effort to constrain our
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interpretations of the regression analyses to those brain regions known to be significantly
atrophic and highly likely to have disease. For example, a significant correlation between
a nonatrophied area and a PACT score could otherwise be attributed to factors that are
independent from disease and instead related to nonspecific factors such as age. The
height threshold for the regression analyses was set at p < .005 (uncorrected). The
threshold was set at p < .05 for the planning regression due to limited variance in
planning scores. We accepted as significant a cluster with a volume of 30 adjacent voxels
and a peak voxel Z-score > 3.09 (equivalent to p < .001).
White matter imaging. DWIs were preprocessed with PipeDream and ANTS, as
above. We removed motion and distortion artifacts by affine coregistration of each DWI
to the unweighted (b = 0) image. We computed DTs using a linear least squares algorithm
(Salvador et al., 2005) implemented in Camino (Cook et al., 2006), and reoriented tensors
using the preservation-of-principal-directions algorithm (D. C. Alexander et al., 2001).
We computed FA from the DT image for each subject, correcting distortion between T1
and DT images by registering the FA image to the T1 image. We warped each
participant’s T1 image to the template via the symmetric diffeomorphic procedure in
ANTS; then warped the FA image to template space by applying the T1-to-template
warps.
We smoothed FA images using a 4mm FWHM isotropic Gaussian kernel. We
performed DTI analyses of FA in SPM8 using the two-samples t-test module. We
analyzed DTI volumes using an explicit mask (FA > 0.25) to constrain comparisons to
regions of white matter. To compare bvFTD participants to healthy seniors, we used a
p < .005 (FDR-corrected) height threshold and a 200-voxel extent. We constrained
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regression analyses to white matter tracts with reduced FA using an explicit mask
generated from the results of the direct comparison with healthy seniors. We limited our
analyses to white matter tracts with significant disease, as above, to constrain our
interpretation to disease-specific neuroanatomical regions. Using a deterministic
tractography procedure in Camino (Cook et al., 2006) we tracked white matter fibers in a
healthy elderly template generated using the DTI sequence described above. We retained
fiber tracts that passed through voxels of reduced FA to define the mask for regression
analyses and accepted as significant a cluster with a volume of 150 adjacent voxels and a
peak voxel Z-score > 3.3 (equivalent to p < .0005).
Results
Behavioral data results. Mean apathy FxS score on the NPI for the bvFTD group
was 5.27 ± 3.3. Mean caregiver distress associated with apathy was 2.77 ± 1.4. Caregiver
distress scores and FxS scores were moderately correlated (rho = 0.53; p = .03).
Table 7 summarizes the performance on the PACT measures. Between-group
comparisons revealed that apathetic bvFTD participants had slower latencies than NC on
all three measures of GDB: initiation (t[33] = 2.26, p = .03; planning (t[33] = 4.79,
p < .001; and motivation (t[33] = 2.17, p = .03).
Table 7
Mean (S.D.) Reaction Time Scores for PACT Performance
PACT score

Control (n = 17)

bvFTD (n = 18)

p-value

Initiation

364.2ms ± 54.0

587.50ms ± 404.3

.03

Planning

1023.76ms ± 139.9

1754ms ± 612.5

< .001

Motivation

522.31ms ± 113.6

916ms ± 715.5

.03
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Imaging results.
Grey matter imaging. Figure 1 illustrates widespread reduction in grey matter
density (green) in lateral (Panel A) and medial (Panel B) frontal and temporal regions in
bvFTD compared to controls. Table 8 summarizes the location of peak voxels in
significantly atrophic clusters.
The results of the regression analysis relating PACT performance to reduced grey
matter density are also summarized in Table 8. Initiation performance was related to
ACC (Figure , Panel C, purple). Planning performance was related to dlPFC (Figure 1,
Panel D, red). Motivation performance was related to OFC (Figure 1, Panel E, blue).

Figure 1. Significant atrophy in behavioral variant frontotemporal degeneration, and
regressions relating Philadelphia Apathy Computerized Test performance to grey matter
density (n = 18)1.
Note: 1. Panel A and B: Anatomic distribution of significant grey matter atrophy in
participants with behavioral variant frontotemporal degeneration (green). Panel C:
Significant regressions relating initiation performance to cortical atrophy in anterior
cingulate (purple) at y = 40. Panel D: Significant regressions relating planning
performance to cortical atrophy in dorsolateral prefrontal cortex (red) at y = 22. Panel E:
Significant regressions relating motivation performance to cortical atrophy in
orbitofrontal cortex (blue) at y = 42. See text and Table 8 for details.
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Table 8***
Anatomic Locus of Peak Voxels in Clusters Relating PACT Scores to Grey Matter
Atrophy (n = 18) and White Matter Integrity in bvFTD (n = 15)
Anatomic locus
(BRODMANNAREA)1

MNI coordinates2
X

Y

Z

Z-score of peak
voxel

Cluster size
(voxels)

behavioral variant frontotemporal degeneration < Eld (grey matter atrophy)
L superior frontal gyrus (10)

-22

46

26

4.65

96

R rostral prefrontal (11)

22

52

4

5.17

362

R middle frontal gyrus (9)

20

26

38

5.06

106

R inferior frontal gyrus (44)

40

8

28

5.84

401

-22

20

-6

4.69

194

R subcallosal gyrus (25)

16

18

-8

5.24

524

R parahippocampal gyrus (27)

18

-34

-2

6.25

14067

R fusiform gyrus (20)

40

-34

-20

4.51

99

R middle temporal gyrus (20)

58

-32

-18

4.70

94

R inferior temporal gyrus (37)

54

-52

-10

4.90

149

R inferior parietal lobule (40)

34

-34

38

5.10

64

L insula

behavioral variant frontotemporal degeneration Initiation Regression (grey matter)
R dorsal anterior cingulate gyrus (32)

22

16

42

4.87

52

L dorsal anterior cingulate gyrus (32)

-14

42

14

4.30

74

behavioral variant frontotemporal degeneration (grey matter)
R middle frontal gyrus (9)

22

14

44

3.28

56

L middle frontal gyrus (11)

-20

40

-22

3.10

104

behavioral variant frontotemporal degeneration Motivation Regression (grey matter)
L medial orbital frontal gyrus (11)

-4

44

-16

4.61

42

R inferior frontal gyrus (46)

40

38

10

3.90

42

R inferior frontal gyrus (47)

34

34

2

3.17

78

L inferior frontal gyrus (47)

-48

24

-6

3.52

34

R cingulate gyrus (32)

22

18

40

5.41

63

L cingulate gyrus (32)

-14

42

14

4.16

77

behavioral variant frontotemporal degeneration < Eld (reduced fractional anisotropy)
L uncinate fasciculus

-33

2

-9

6.30

13222

R uncinate fasciculus

38

7

-28

5.15

1388

-34

14

22

5.87

7623

L inferior frontal gyrus white matter
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Anatomic locus
(BRODMANNAREA)1

MNI coordinates2

Z-score of peak
voxel

Cluster size
(voxels)

X

Y

Z

3

-21

30

4.60

355

R anterior corona radiata

11

34

-13

4.54

1244

Body of corpus callosum

-7

6

25

4.44

1546

3

-8

16

6.42

541

L posterior limb of internal capsule

-18

-8

5

4.17

347

L crus of fornix or striaterminalis

-14

-30

13

4.76

261

Splenium of corpus callosum

12

-33

11

5.15

1220

R inferior temporal gyrus white matter

47

-48

-13

5.10

335

R cingulum

R column and body of fornix

behavioral variant frontotemporal degeneration Initiation Regression (fractional anisotropy)
L cingulum

-7

30

15

3.43

1693

Body of corpus callosum

2

8

25

3.52

Same cluster as
cingulum

Genu of corpus callosum

13

52

14

4.03

1056

Genu of corpus callosum

-12

53

23

3.39

382

16

39

-16

4.84

2587

-14

32

-16

4.29

4609

R uncinate fasciculus
L medial orbital gyrus white matter

behavioral variant frontotemporal degeneration Planning Regression (fractional anisotropy)
R superior longitudinal fasciculus

25

-40

34

3.47

191

L inferior frontal gyrus white matter

-49

31

5

3.54

217

R inferior frontal occipital fasciculus

18

25

-3

5.10

1092

Genu of corpus callosum

12

47

26

4.23

650

Body of corpus callosum

15

15

42

3.82

533

Body of corpus callosum

10

6

58

3.74

162

R posterior corona radiata

20

-26

37

3.93

258

L superior corona radiata

-20

-14

38

3.54

269

-5

-8

37

3.45

239

L. cingulum

behavioral variant frontotemporal degeneration Motivation Regression (fractional anisotropy)
R uncinate fasciculus

16

39

-16

4.67

2537

-13

33

-16

3.98

1678

Genu of corpus callosum

16

51

15

3.92

1091

Genu of corpus callosum

2

25

7

3.77

2593

L medial orbital gyrus white matter

Note. 1. The corresponding Brodmann area is indicated by the figure in parentheses. L = left; R = right. 2.
Peak locus of these clusters are derived from MNI (= Montreal Neurological Institute) space converted to
Talairach space using Montreal Neurological Institute.
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White matter imaging. bvFTD showed widespread reductions in FA in bilateral
frontal and temporal white matter relative to controls (Figure 2, Panel A, green). Peak
voxels in clusters of significantly reduced FA, and regressions of FA with PACT scores
are summarized in Table 8. Initiation performance was related to FA in cingulum, UNC
fasciculus, inferior longitudinal fasciculus, and corpus callosum (CC) (Figure 2, Panel B,
purple). Planning performance was related to FA in superior longitudinal fasciculus
(SLF), right inferior frontal-occipital fasciculus, rostral frontal corona radiata, and CC, as
well as posterior thalamic radiations (Figure 2, Panel C, red). Finally, motivation
performance was related to FA in UNC as well as CC, corona radiata , and inferior
longitudinal fasciculus (Figure 2, Panel D, blue).

Figure 2. Reduced white matter integrity in behavioral variant frontotemporal
degeneration, and regressions relating Philadelphia Apathy Computerized Test
performance to reduced fractional anisotropy (n = 15)1.
Note: 1. Panel A: Anatomic distribution of reduced fractional anisotropy in participants
with behavioral variant frontotemporal degeneration (green). Panel B: Significant
regressions relating initiation performance to reduced fractional anisotropy including
cingulum (purple). Panel C: Significant regressions relating planning performance to
reduced fractional anisotropy including right superior longitudinal fasciculus (red). Panel
D: Significant regressions relating motivation performance to reduced fractional
anisotropy in uncinate fasciculus (blue). See text and Table 2.3 for details.
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Discussion
This study investigated the behavioral and neural basis of GDB by examining
bvFTD patients who display prominent apathy. We found that apathetic bvFTD patients
are impaired on each of the three processes thought to contribute to apathy due to deficits
in GDB: initiation, planning, and motivation. These three GDB processes were associated
with disease in three distinct frontal grey matter regions and in white matter projections
between these regions and other brain areas. Specifically, initiation difficulty related to
atrophy in the ACC and to disease in the cingulum, poor planning related to atrophy in
dlPFC and disruption in SLF and frontal corona radiata, and impoverished motivation
related to atrophy in OFC and UNC disease. These findings are consistent with a threecomponent model of GDB that can contribute to apathy in bvFTD.
The PACT identified impairment in the three components of GDB: initiation,
planning and motivation. A deficit in any one of these can contribute to apathy in bvFTD.
Moreover, each of these deficits was associated with selective disruption of a large-scale
neuroanatomic network important for GDB. Consider first a deficit in initiating a
behavior that is related to ACC and white matter tracts including the cingulum.
Considerable work has suggested that the ACC is important to initiate a behavior (Tekin
& Cummings, 2002). Researchers previously implicated the ACC in processes that
influence action initiation in healthy adult studies (Mulert, Gallinat, Dorn, Herrmann, &
Winterer, 2003). Others implicated the ACC in initiation difficulty in those with frontal
lobe injury. For example, the akinetic mute state is a medical term describing patients
who tend to sit quietly in the same position all day without speaking or talking, and
researchers related this specifically to ACC damage (Mega & Cohenour, 1997). The ACC
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has been well studied in dementia, and neuroimaging evaluations have linked the ACC
region to apathy in various groups. Researchers associated reduced grey matter density in
the cingulate gyrus with apathy in patients with bvFTD (Massimo et al., 2009; Zamboni
et al., 2008) and PD (Reijnders et al., 2010). Previous DTI studies investigating white
matter disease and apathy showed an association with the cingulum, which has reciprocal
connections between ACC and the medial orbitofrontal region that is important for
motivation (Hahn et al., 2013; Ota et al., 2012). In healthy adults, ACC and dlPFC
structures work in concert during complex tasks that require attentional control, likely to
be mediated through the cingulum (Silton et al., 2010). Therefore, disease in ACC and
interruption of projections between ACC and other structures important for GDB may
contribute to apathetic behavior.
Researchers associated deficits in the planning component of GDB with atrophy
in the dlPFC and reduced FA in related white matter tracts, including SLF and frontal
corona radiata. fMRI studies of healthy adults suggested that dlPFC contributes to
planning and working memory (Di, Rypma, & Biswal, 2013). Patients who suffer from
dysfunction in these circuits failed to elaborate, manipulate, and integrate important
information needed for behavior that is goal-directed. Studies suggested a relationship
between apathy and poor executive function in bvFTD (Eslinger et al., 2012; Zamboni et
al., 2008). Eslinger and colleagues (2012) found caregiver apathy scores were
significantly correlated with executive-function measures, suggesting that apathy
emanates in part from difficulty manipulating and integrating elements of a plan to
achieve a goal (Eslinger et al., 2012). Imaging studies of patients with FTD and AD have
linked apathetic behavior to atrophy in dlPFC as well (Massimo et al., 2009; Zamboni et
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al., 2008). In addition, a previous study of patients with amnestic mild cognitive
impairment revealed a relationship between reduced FA in the SLF and apathy (Cacciari
et al., 2010). The SLF is a prominent white matter tract interconnecting the frontal,
temporal, and parietal lobes, and this tract has been implicated in the integration of these
diverse regions involved in planning (Genova, DeLuca, Chiaravalloti, & Wylie, 2013).
We found that difficulty with the motivation component of GDB is associated
with atrophy in the OFC and related white matter tracts, including UNC. Evidence from
healthy subject fMRI studies suggested that the OFC plays a role in interpreting value
and reward-related information (Hare et al., 2010). Researchers have examined deficits in
processing value and reward extensively in patients with FTD because they appear to
have early degeneration of this frontal circuit in comparison to other neurodegenerative
conditions (Rabinovici et al., 2007). Poor motivation can occur in these patients because
they have decreased reactivity to positive “reward” and negative “punishment” signals,
thereby making goal-selection difficult (Levy & Dubois, 2006). Experimental evidence,
however, emphasized that patients with bvFTD and other diseases affecting OFC have
the greatest difficulty interpreting “punishment” signals (Grossman et al., 2010). Imaging
evidence from patients with bvFTD emphasized the link between OFC and apathetic
behavior (Massimo et al., 2009). Fludeoxylucose PET brain activity is decreased in OFC
in bvFTD patients with apathetic compared to nonapathetic patients (Peters et al., 2006).
UNC is a major tract connecting the anterior temporal lobe with the medial and lateral
prefrontal cortex areas known to be important for GDB (Kable & Glimcher, 2007). DTI
studies performed in AD and PSP implicated UNC in apathy (Hahn et al., 2013) and our
findings extend this to bvFTD.
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Although we suggest specific contributions of neural mechanisms to distinct
components of GDB, we do observe some overlap across measures. For example, our
grey matter observations suggested that the cingulate may contribute to both initiation
and motivation. In fact, post hoc correlation analyses of PACT measures revealed a
significant correlation between initiation and motivation performance (rho = .78;
p < .001). Post hoc correlations, however, are not significant between other PACT
measures (all p > .05, Bonferroni corrected) and we otherwise observed distinct
neuroanatomical regions contributing to components of GDB. It will be important for
future work to identify quantitative measures of initiation and motivation that are not
interdependent.
This is the first study using the impaired GDB model to help explain apathy in
ND, and our findings have potentially important implications for its treatment. Prior
measures to manage apathy have not been effective (Mizrahi & Starkstein, 2007). One
reason for this failure may be the way apathy is conceptualized. That is, apathy is
currently viewed homogeneously, as if derived from a single source; our findings suggest
that each of three components of GDB contribute to apathetic behavior. Treatments, thus,
have tended to focus on improving the initiation component of GDB, often with
stimulants (Devos et al., 2013), even though apathy may be due to a deficit in one of the
other components of GDB.
Some limitations should be kept in mind when considering our findings. Although
our sample was larger than in prior investigations of apathy, we nevertheless studied a
small number of patients and power in the imaging studies may have been insufficient to
detect every anatomic region associated with apathy. Because floor effects in performing
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the planning measure limited variance, we were forced to use a liberal threshold for our
hypothesis-driven grey matter analyses. Last, we do not have neuropathological
confirmation of the diagnoses of these patients.
With these caveats in mind, we conclude that apathetic behavior in bvFTD can be
characterized as an impairment in GDB that is a multicomponent process including
initiation, planning, and motivation. These three processes are supported by a large-scale
neural network constituting the neuroanatomic basis for GDB, including distinct grey
matter regions in the frontal lobe and related white matter projections.

	
  

63
CHAPTER 3: DIFFERENTIATING IMPAIRMENTS IN GOAL-DIRECTED
BEHAVIOR: APATHY IN FRONTOTEMPORAL DEGENERATION
Lauren Massimo MSN1, 2*†, John P. Powers BS1†, Lois K. Evans PhD, RN2, Corey T.
McMillan PhD1, Katya Rascovsky PhD1, Paul Eslinger PhD3, Mary Ersek, PhD, RN2,
Brianna Morgan, BSN, RN 2, David J. Irwin MD1, & Murray Grossman MD EdD1*
1

Frontotemporal Degeneration Center, Department of Neurology, University of

Pennsylvania Perelman School of Medicine
2

University of Pennsylvania, School of Nursing

3

Penn State Hershey Milton S. Hershey Medical Center, Department of Neurology

(Prepared according to guidelines for submission to American Journal of Geriatric
Psychiatry)
Abstract
Apathy involves a reduction in GDB. In the current study, we sought to identify
three subtypes of apathy in bvFTD by differentiating impairments in GDB. Twenty
patients with bvFTD and 17 matched healthy controls participated in this study. We
measured RTs using a novel computerized procedure—PACT—to quantify performance
for each of three components of GDB—initiation, planning, and motivation—and to
derive individualized patient-apathy profiles. We explored neuroanatomical associations
of these performance profiles using a region of interest volumetric analysis. We found
isolated deficits in each component of GDB in 12 (60%) bvFTD participants, including
two (10%) with an isolated initiation impairment, eight (40%) with an isolated planning
impairment, and two (10%) with an isolated motivation impairment. An additional eight
(40%) participants were impaired on multiple components of the PACT. Voxel-based
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morphometry revealed that those participants with reduced initiation had ACC atrophy;
those with impaired planning had atrophy in dlPFC, and those with poor motivation had
OFC atrophy. Apathy is a complex, multicomponent syndrome, and we found
quantitative reduction in each of the three processes contributing to apathy in bvFTD.
Introduction
GDB describes a set of related processes that support independent, goal-obtaining
action in everyday activities (Brown & Pluck, 2000). Core components of GDB include
initiation, planning, and motivation. We adopted the perspective that apathy is a
reduction in GDB which arises when one or more GDB processes are compromised
(Levy & Dubois, 2006). We developed a quantitative measure to directly assess the
behavioral and neuroanatomic basis for apathy in bvFTD.
Apathy is reported to be the most common initial behavioral syndrome in bvFTD,
occurring in up to 90.5% of patients (Diehl-Schmid et al., 2006). Researchers associated
akinetic mutism and abulia that emphasize a lack of initiation with apathy (Starkstein &
Leentjens, 2008). Further, others related apathy to executive deficits that limit planning
needed for goal-obtaining actions (Eslinger et al., 2012). Still others have broadly defined
apathy as reduced motivation (Marin, 1996). Each of these characteristic behaviors can
be seen in apathetic bvFTD patients. We assessed initiation, planning, and motivation
components of GDB using a novel computerized RT test—PACT—in apathetic patients
with bvFTD.
Researchers think apathy arises following degeneration of frontal-subcortical
circuits (Levy & Dubois, 2006). Consistent with the view that a single-component model
may be insufficient to explain apathy, neuroimaging studies associate apathy with several
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frontal regions (Massimo et al., 2009; Rosen et al., 2005; Zamboni et al., 2008). Previous
imaging studies in persons without apathy suggested that poor initiation relates to ACC disease,
(Kotchoubey et al., 2003; Reijnders et al., 2010); poor planning relates to disease in dlPFC,
(Kaller et al., 2011; Unterrainer, Rahm, Kaller, Leonhart, et al., 2004; van den Heuvel et al.,
2005), and reduced motivation relates to disease in OFC (Diekhof et al., 2011; Sescousse et al.,
2010). A specific process of GDB suffers when one of these frontal areas is compromised,
resulting in apathetic behavior. We hypothesized that patients with bvFTD have
differentiated profiles of apathy, and that these relate in part to patients’ neuroanatomic
distribution of disease.
Methods
Participants. We examined 20 apathetic patients with bvFTD (female = 5) and
17 demographically matched healthy controls (NC). Experienced cognitive neurologists
from the Department of Neurology, University of Pennsylvania (MG, DJI) evaluated and
recruited all patients. bvFTD patients were diagnosed using published criteria (Rascovsky
et al., 2011). Neurologists assessed patients as having apathy based on the apathy
subscale of the NPI using an FxS score ≥ 1. As summarized in Table 9, we included only
participants with mild disease (MMSE ≥ 20) to minimize confounding factors related to
severity of cognitive impairment. Geriatric Depression Scale-Short Form (Sheikh &
Yesavage, 1980) scores ≤ 5 demonstrated that participants were not depressed, as
depression also could confound our findings. All subjects and responsible caregivers
participated in an informed-consent procedure approved by the University of
Pennsylvania IRB.
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Table 9
Mean (S.D.) Demographic Features of Participants
NC (n = 17)

bvFTD (n = 20)

Age (YEARS)

67.12±10.82

63.1±5.88

Education (Years)

15.35±2.91

16.65±2.79

Mini-Mental State Exam (max score = 30)

29.47±0.87

26.45±2.48

Disease duration (Years)

na

3.4±1.64

Mean Neuropsychiatric Inventory
Apathy frequency by severity (max score =
12)

na
5.54±3.1

The initial clinical diagnosis of bvFTD was consistent with results of serum
studies, structural imaging such as MRI or CT, studies of cerebrospinal fluid, and
functional neuroimaging studies such as single-photon emission computerized
tomography or PET (when available). Exclusion criteria included the presence of other
neurological conditions such as stroke, closed-head trauma, or hydrocephalus; primary
psychiatric disorders such as depression or psychosis; a systemic illness that can interfere
with cognitive functioning; or use of soporific medications because of their sedating sideeffects. Patients may have been taking a fixed dosage of a cholinesterase inhibitor (e.g.,
donepezil, rivastigmine, or galantamine) or memantine, or a low dosage of a nonsedating
antidepressant (e.g., serotonin-specific reuptake inhibitors such as sertraline) or an
atypical neuroleptic agent (e.g., quetiapine), indicated clinically.
The Philadelphia Apathy Computerized Test (PACT). The PACT is a novel
computerized RT test designed to quantify each core component of GDB: initiation,
planning, and motivation. The PACT was developed based on a review of experimental
paradigms and clinical observations (Elliott et al., 2010; Jenkins et al., 2000; Ruh et al.,
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2010). There are 48 trials in each of the three conditions, one for each GDB component.
A practice block, in which participants receive instructions about task performance and
12 practice trials, precedes each experimental condition.
In each condition, a trial begins when the subject depresses a computer “start” key
with the index finger. In response to a signal, RT1 is the latency for a participant to lift
the finger from the start key, and RT2 is measured as the time to depress the target key
after lifted from the start key. Total latency is the sum of RT1 and RT2. We
counterbalanced all stimuli and randomly distributed them in each condition.
In the simplest condition, designed to measure the initiation component, a
participant begins a trial by depressing the start key; when a stimulus appears centrally on
the computer screen, the participant lifts the finger from the start key, then depresses a
fixed central target key in response to this stimulus; the signal occurs on average
1,250msec (range 500–2,000msec) after depressing the start key. Initiation is assessed by
measuring RT1.
To measure the planning component, we administered two levels of task difficulty.
In the first level, participants depress the start key and then are presented with randomly
ordered lateralized visual stimuli on the computer screen. Participants are instructed to
press a left or right target key (stimulus appears on the left, then go left; stimulus appears
on right, then go right. In the second, more complex level, one of two lateralized keys is
pressed contingent on the combination of patterns in a central visual stimulus (stimulus
appears on the left, then go left; stimulus appears on right, then go right). These patterns
are visually available to participants during performance to minimize task-related
working memory confounds. We used two measures to identify a planning deficit: total
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latency in the complex planning condition and the difference in response times between
these two levels of difficulty.
To assess motivation, we repeated the simplest condition with an explicit
monetary reward incentive; a system of “monetary units,” was exchanged for actual
money at the end of the study, for responding correctly and more rapidly than during the
simple task. Participants see their response speed during the unrewarded condition on the
computer screen, and receive feedback about their “rewarded” response speed on the
computer screen after each trial. Sensitivity to negative consequences is also assessed
with a “penalty” condition. In this “penalty” condition, participants are given a number of
monetary units at the beginning of the task. If they do not respond correctly and more
rapidly, they lose units. We use the total latency in the penalty condition to assess
motivation because previous work has shown that bvFTD patients appear to be relatively
insensitive to negative feedback (Grossman et al., 2010). The point system was adjusted,
without knowledge of the participant, so that each participant received the same total
actual payment at the end of the study.
Behavioral criteria for developing apathy subtypes. We developed
performance profiles according to predetermined criteria that correspond to each of the
components of GDB, and these were ascertained in individuals using latency means and
standard deviations over 48 trials in each of the three experimental conditions (see Table
10). Individual participant z-scores were generated for NC performance for each
condition. Significant impairments were defined as a z-score ≥ 2 for each component.
Most participants with impairments in initiation and/or motivation also had a planning
impairment, consistent with the dysexecutive profile typically seen in bvFTD (Rascovsky
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et al., 2011). For participants whose impairment was limited to planning, we assumed this
component was the sole contributor to apathy. To better distinguish which components
contributed most to apathy in those with multiple impairments, we implemented the
application of the planning criteria in a stepwise fashion. Thus, we subjected planningimpaired participants who also had deficits in initiation and/or motivation to a second
level review; we only classified those participants who also had greater slowing on the
complex planning condition compared to the simpler planning condition in the planningimpairment subtype.
Table 10
Behavioral Criteria for Apathy Subtypes
Subtype profile

Criteria

Initiation

Significantly slow Reaction Time 1 in simple condition
Does not have slowed latencies for complex condition
Able to improve performance on the simple condition in response to penalty.

Planning

Significantly slowed on complex planning condition and, for those with multiple
impairments, significant slowing on the complex planning condition compared to the
simpler planning condition
Does not have slowed initiation for simple condition
Able to improve performance on the simpler planning condition in response to reward
or “penalty.”

Motivation

Significantly slowed on simple penalty condition and fails to improve performance
with penalizing motivators
Does not have slowed initiation for simple condition
Does not have slowed latencies for complex condition.

Neuroimaging data. High-resolution T1-weighted 3-dimensional spoiled
gradient echo images were acquired on a Siemens 3.0T Trio scanner with an 8-channel
coil (repetition time = 1,620msec, echo time = 3msec, slice thickness = 1.0mm, flip
angle = 15°, matrix = 192 × 256, and in-plane resolution = 1.0 × 1.0mm). Before
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normalization, each participant’s structural image was segmented into tissue classes using
Atropos, a voxel-based segmentation tool that segments the brain into grey matter, white
matter, and cerebrospinal fluid (Avants, Tustison, Wu, et al., 2011). We preprocessed all
images processed using PipeDream (Sourceforge, 2014) and ANTS (Penn Image
Computing & Science Lab, 2014). Researchers previously demonstrated the ability of
this method to accurately normalize large-scale data as in studies of patients with ND
(Avants et al., 2008; Avants, Tustison, Song, et al., 2011). We used a symmetric
diffeomorphic deformation for registration to avoid bias toward the reference space for
computing the mappings (Avants, Tustison, Song, et al., 2011). Processing involved
mapping T1-weighted structural MRI to an unbiased average-shape and averageappearance template derived from a representative population consisting of 25 healthy
seniors and 25 patients with FTD (J. Kim et al., 2008). This diffeomorphic method for
registration and normalization avoids the need to use identical participants in the local
template (Avants & Gee, 2004). Images were then warped to Montreal Neurological
Institute space for analysis. We calculated grey matter probability images as a
quantitative measure of grey matter density.
Structural MRI data were available for 19 bvFTD participants who completed the
PACT. We obtained a priori defined ROI for ACC, dlPFC, and OFC. These ROIs were
selected based on literature suggesting that poor initiation relates to disease in ACC
(Kotchoubey et al., 2003; Reijnders et al., 2010), poor executive function relates to
disease in dlPFC (Kaller et al., 2011; Unterrainer, Rahm, Kaller, Leonhart, et al., 2004;
van den Heuvel et al., 2005), and reduced motivation relates to disease in OFC (Diekhof
et al., 2011; Sescousse et al., 2010). We used a standardized AAL and parcellation
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method (Tzourio-Mazoyer et al., 2002) to label the following ROIs. The first ROI (e.g.,
initiation) was centered on the ACC (AAL label = ACIN). The second (e.g., planning)
ROI was centered on the middle frontal gyrus portion of the dlPFC (AAL label = F2).
The last ROI (e.g., motivation) was composed of the orbital regions of the middle and
superior frontal gyri (AAL labels = F10, F20). Additionally, we used a control ROI in the
MT region (AAL label = T2). We chose this region because it is an area implicated in
bvFTD (Brettschneider et al., 2014), but we did not hypothesize it to contribute to GDB.
For all ROIs, we computer the mean GMP value and divided it by the subject’s
individual average whole-brain GMP value. Using this ratio, we examined relative
differences in regional composition of grey matter in frontal areas thought to underlie
GDB impairments and the control region in the lateral temporal lobe.
Results
Behavioral results. Mean (SD) NPI apathy FxS score for the bvFTD group was
5.54 ± 3.1, which suggests moderate levels of global apathy. Table 11 summarizes mean
group performance on PACT measures. Between-group comparisons found that apathetic
bvFTD participants have significantly slower latencies than NC on each GDB measure:
Initiation (t[35] = 2.35, p = .03; Planning (t[35] = 5.58, p < .001; Motivation (t[35] = 2.60,
p = .01). Although caregiver distress scores were correlated with NPI FxS scores for
apathy, PACT scores did not correlate with either caregiver distress scores or NPI apathy
scores.
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Table 11
Mean (SD) Latencies for each PACT Score in all Participants
PACT score

Control (n = 17)

bvFTD (n = 20)

364.31ms ±54.06

584.03ms ±381.60

.03

Planning (complex
condition)

1023.79ms ±140.01

1845.75ms ±592.89

< .001

Motivation (penalty
condition)

522.22ms ±113.54

967.67ms ±675.15

.01

Initiation

p-value

Note. PACT = Philadelphia Apathy Computerized Test; bvFTD = behavioral variant frontotemporal
degeneration.

Inspection of individual patient z-score profiles identified 12 patients (60%) with
an impairment on a single GDB component. As summarized in Table 12, two (10%) had
an initiation deficit, eight (40%) had a planning deficit, and two (10%) had a motivation
deficit. Four patients (20%) had an initiation impairment combined with impaired
planning or motivation, and four (20%) were impaired across all three GDB components.
There were no differences in any demographic variables between participants with
impairments in single or multiple components of GDB.
Table 12
Number of bvFTD Participants According to Apathetic Subtype (N = 20)
Subtype

N (%)

Single component

12 (60%)

Initiation

2 (10%)

Planning

8 (40%)

Motivation

2 (10%)

Multicomponent

8 (40%)

Initiation and planning

3 (15%)

Initiation and motivation

1 (5%)

Initiation, planning, and motivation

4 (20%)
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Neuroimaging results. We examined differences in regional GMP in bvFTD
participants with MRI data (n = 19) based on PACT performance. Paired samples t-tests
were conducted to compare GMP in a priori ROIs to the control ROI in the MT region.
Participants with any initiation deficit (n = 9) showed significantly reduced grey matter in
the ACC region (M = 1.03, SD = 0.10) compared to the MT region (M = 1.19,
SD = 0.02); t(8) = 3.59, p = .007). Participants with any planning deficit (n=13) showed
reduced grey matter in the dlPFC (M = 0.99, SD = 0.04) compared to the MT region
(M = 1.17, SD = 0.03); t(12) = 8.05, p ≤ .001). Last, participants with any motivation
deficit (n = 10) showed reduced grey matter in the OFC (M = 1.07, SD = 0.05) compared
to the MT region (M = 1.17, SD = 0.04), t(9) = 3.20, p = .01).
We confirmed these findings in every participants with a single apathy deficit.
Thus, we evaluated the specificity of these imaging results with a post hoc assessment of
GMP in each participant with a single deficit in each apathy component. Although the
small number of participants with single impairments precluded statistical analysis, we
confirmed that participants with a single impairment in initiation (n = 2) had reduced grey
matter density in the ACC compared to the MT region, participants with a single
impairment in planning (n = 7) had reduced grey matter density in the dlPFC compared to
the MT region, and participants with a single impairment in motivation (n = 2) had
reduced grey matter density in the OFC compared to the MT region (see Figure 3).
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Figure 3. Regions of interest selected from the automated anatomical labeling template.
Note: Three parcellated gyral-based regions of interest (lateral and medial view of the
right hemisphere). Red = anterior cingulate cortex (initiation); green = dorsolateral
prefrontal cortex (planning); blue = orbitalfrontal cortex (motivation);
magenta = midtemporal (control region).
Discussion
This study examined differentiated impairments in GDB in bvFTD patients who
displayed prominent apathy. We identified three components of apathy based on impaired
GDB processes defined by performance on an objective behavioral instrument:
impairment of initiation, planning, and motivation. Our observations support that apathy
is a multicomponent syndrome, and specific deficits in initiation, planning, and
motivation are associated with discrete regions of the frontal lobe.
Understanding the precise nature of the mechanisms that contribute to apathy is of
clinical and theoretical importance. At present, no one has identified effective treatments
for apathy (Drijgers, Aalten, Winogrodzka, Verhey, & Leentjens, 2009). This may be due,
at least in part, to consideration of apathy as a single, undifferentiated phenomenon when,
in fact, specific components may be differentially compromised. From this perspective,
treatment of an initiation deficit may not benefit an individual with impaired motivation.
A crucial step toward improving management of apathy, thus, may involve improving
understanding of the mechanisms that contribute to apathy. According to a GDB model,
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at least three core processes—initiation, planning, and motivation—must be functional to
translate an idea into a goal-obtaining action (Brown & Pluck, 2000). Impaired initiation
limits spontaneous action and results from difficulty activating cognitive and motor
functions to initiate an act or thought. Plans of action often consist of multiple mental
steps, and compromised planning may limit the ability to manipulate the components of a
task mentally in order to execute an action. Impaired motivation compromises the ability
to process the internal and external determinants that augment the rewarding value or
help avoid the negative consequences associated with the intention to act (Levy & Dubois,
2006). The present study used the GDB model to demonstrate differentiated deficits in
these three components of apathy in bvFTD.
An international task force proposed criteria for the clinical diagnosis of apathy in
neurodegenerative conditions, drawing a distinction between behavioral, cognitive, and
emotional domains (Robert et al., 2009). These correspond in part to the initiation,
planning, and motivation components of apathy suggested by the GDB model. One of the
primary obstacles to advancing knowledge in this area has been the absence of a
quantitative method that directly measures specific mechanisms contributing to apathy.
Although several global apathy-assessment tools exist for the cognitively impaired
population, there is a lack of agreement on the interpretability of the data from these
measures (Clarke et al., 2011). This lack of consensus may be due in part to the fact that
traditional instruments to ascertain apathy commonly use proxy report. This approach is
subject to caregiver confounds such as burden and strain that may impact the evaluation.
Indeed, we did find the ascertainment of apathy by proxy report was biased by caregiver
stress. Caregiver distress scores and FxS scores were correlated (r = .47; p = .04),
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suggesting that estimated symptom severity in bvFTD was likely biased by caregiver
distress.
Further, beyond confirming the presence of apathy, current instruments such as
the NPI are ineffective in identifying different subtypes of apathy (Chow et al., 2009).
One goal of the present study was to quantify components of GDB in apathetic
participants in an objective manner, minimally confounded by proxy report. In a series of
bvFTD patients with apathy, we identified individuals who demonstrated single deficits
in each of the hypothesized components of GDB, providing some validation for this
approach. Additional work is needed to examine these components in larger groups of
participants with bvFTD and other neurodegenerative conditions.
The failure to initiate behavior leads to a subtype of apathy such that an individual
is unable to generate a signal significant enough to begin a response. The akinetic-mute
state describes individuals who sit quietly in the same position all day without speaking,
due to anterior cingulate damage (Mega & Cohenour, 1997). Abulia is the loss of
initiative and spontaneous thought, and external stimulation is needed to start mental
activity or speech (Quaranta, Marra, Rossi, Gainotti, & Masullo, 2012). The initiation
condition of the PACT assesses this GDB component quantitatively by measuring the
latency to initiate a movement in response to a visual signal. We found that some
apathetic bvFTD individuals are significantly impaired only on this component of GDB.
Moreover, this impairment was associated with anterior cingulate atrophy.
Initiation difficulty is not the only basis for apathetic behavior. The ability to
execute an action is also highly dependent on the cognitive processes needed to plan,
organize, and carry out goals. Apathy related to “cognitive inertia” can result from
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impairments in executive functions such as planning, working memory, and taskswitching (Burgess, 2000; Levy & DuBois, 2006). Apathy in AD has been related to
difficulty performing several tasks interchangeably (Esposito et al., 2010). In PD,
performance on standardized tests of planning was associated with severity of apathy
(Weintraub et al., 2005). Poor planning was the most prevalent single component of
apathy found to be impaired in our bvFTD sample. This is not surprising, given that a
dysexecutive neuropsychological profile is a common finding in bvFTD (Rascovsky et al.,
2011). Moreover, we found that this subtype of apathy is associated with lateral
prefrontal atrophy. Other work has associated executive difficulty in bvFTD with lateral
prefrontal atrophy (Huey et al., 2009).
Another component of GDB is motivation, that is, responsiveness to external and
internal drives that may be positive or negative. Apathy may result from a lack of
responsiveness to reward or risk, thereby making goal-selection difficult (Levy & Dubois,
2006; Rosen et al., 2002; Schultz et al., 2000). Likewise, reduced ability to assess and
interpret consequences of actions, whether positive or negative, can limit motivation
(Zamboni et al., 2008). Patients with bvFTD typically have a greater desire for certain
rewards such as money and social praise, but tend to show less sensitivity to negative
consequences (Grossman et al., 2010; D. C. Perry, Sturm, Wood, Miller, & Kramer,
2013). We found that patients performed faster on the reward condition (compared to the
simple condition without incentive), suggesting they were motivated by a monetary
incentive. Their performance pattern did not change, however, when we took away
monetary units for not performing faster, thereby suggesting relative insensitivity to
negative consequences. In our sample of bvFTD participants, we identified some
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individuals with insensitivity to the motivational component of GDB, associated with
OFC atrophy. Other work has associated limited motivation with ventral frontal atrophy
in bvFTD (Grossman et al., 2010).
Although each of the three components we assessed may contribute to GDB,
clinical observations suggest that deficits in initiation, planning, and motivation may not
be sequential, as some have hypothesized (Levy & Dubois, 2006). Instead, apathy may
arise when any one of these three processes is impaired. For example, patients who have
profound impairments in planning an action may be able to initiate an action and may be
motivated to achieve a goal, but their planning impairments alone may make it difficult to
engage in GDB. Our findings suggest that initiation, planning, and motivation processes
are relatively independent and, when compromised, may each contribute to apathy.
Additional work is needed to confirm these profiles in a longitudinal cohort. Nevertheless,
we found several individuals who appeared to be impaired with multiple components of
GDB. That is, some patients with initiation difficulty also had limitations in planning,
motivation, or both. Although consideration may be given to the possibility that a deficit
in initiation may also lead to additional difficulty in other GDB components, the
observation of independent deficits in each GDB component makes this less likely.
Compared to individuals displaying a multicomponent subtype of apathy, those with a
single GDB deficit did not differ by age, disease duration, and MMSE (all p > .05). This
outcome suggests that variations in apathetic profiles are not easily attributable to
variability in the underlying disease process, but instead are related, at least in part, to
anatomical distribution of disease.

	
  

79
Our findings need to be interpreted in light of several limitations. Our findings
require confirmation in a larger sample of participants. We studied patients with relatively mild
disease, and it would be valuable to extend assessment to more severely impaired patients. We
studied bvFTD particularly because apathy is very common in this condition, these patients do
not have motor limitations such as weakness or involuntary movements that can confound the
quantitative assessment of reduced GDB, and there are no language or visuospatial deficits that
can potentially limit the interpretation of impaired performance. Nevertheless, it would be
important to investigate GDB in apathetic patients with other neurodegenerative conditions
such as AD or PD who also display apathy.
With these caveats in mind, we identified three components of GDB, using a
novel computerized RT test that may show independently impaired results in apathetic
patients with bvFTD. There appear to be at least three distinct sources of apathy,
including a deficit in initiation, planning, or motivation, and these appear to depend in
part on regions in the frontal lobe that support GDB. Impairment in any one or
combination of these components—initiation, planning, or motivation—may emerge as
apathy.
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CHAPTER 4: THE NEURAL BASIS OF APATHY IN FRONTOTEMPORAL
DEGENERATION: A LONGITUDINAL STUDY1
Specific Aims
Apathy, a reduction in GDB (Levy & Dubois, 2006), affects 90% of people with
bvFTD (Diehl-Schmid et al., 2006), a common cause of early onset ND (Vilalta-Franch
et al., 2013). The cognitive and neural impairments associated with apathy make it
difficult to initiate, plan, and motivate activities toward a specific goal, such as dressing
or bathing. These impairments are associated with significant decline in functional ability,
caregiver burden, and increased cost of care due to early institutionalization (Butterfield
et al., 2010; Lechowski et al., 2009; Massimo et al., 2009; Okura et al., 2011). Caregivers
struggle to provide care without hope of relief because current treatments are ineffective
(Mizrahi & Starkstein, 2007). In this interdisciplinary research training grant, I propose
innovative methods to advance understanding of the longitudinal course of apathy, a
clinical manifestation of brain pathology in persons with bvFTD. My long-term goal is to
design tailored interventions targeting reduction and management of apathy and the poorhealth outcomes that accrue to affected individuals and their caregivers. This work will
also serve as a training venue to help me attain my professional goal to become an
independent researcher by developing expertise with new measures of moderators
(environmental factors and genetics), as well as new statistical (longitudinal analysis) and
imaging techniques (diffusion-tensor imaging).
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   	
  
This chapter was submitted as a National Research Service Award for Individual Post-Doctoral
Fellows (F32). It appears here as it does in the submitted application.
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In my dissertation work, funded by an Individual Predoctoral National Research
Service Award (F31NR013306), I used empirical methods to identify three subtypes of
apathy in bvFTD that interfere with GDB: impairments in initiation, planning, and
motivation. Each of these deficits was associated with selective disruption of a largescale neuroanatomic network underlying GDB. Specifically, initiation subtype was
related to atrophy in ACC, the planning subtype was related to atrophy in dlPFC, and the
motivation subtype was related to atrophy in OFC. My preliminary longitudinal data
revealed that decline is restricted to the subtype of initial impairment and does not
generalize to the other subtypes. These distinct types of apathy may benefit from
interventions tailored to mediate each compromised mechanism, but I must first
understand the natural history of these impairments and the biological and environmental
factors that influence the rate of decline. Cognitive-reserve theory is a framework for
understanding these brain–behavior relationships. Using cognitive-reserve theory, I posit
that environmental factors (education, occupation, and leisure activities) are related to
neural connectivity and cognitive strategies that support brain functioning in the face of
ND, and thereby play a moderating role in the rate of longitudinal decline (Steffener &
Stern, 2012). Biological factors that impact longitudinal decline include focal changes in
grey matter and associated white matter tracts and genetic factors such as Apolipoprotein
E (ApoE) and tau haplotype (Morley et al., 2012a; Van Gerven, Van Boxtel, Ausems,
Bekers, & Jolles, 2012; Whitwell et al., 2008). I will examine both types of factors in this
study.
The identification of factors that moderate the clinical expression of disease, in
this case apathy, is an important consideration for identifying persons “at risk” for more
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rapid decline and optimizing interventions for all persons with apathy associated with ND.
This research training proposal is a longitudinal investigation of impaired GDB using
resources from an ongoing program project, “Cognitive and Neural Impairment in
Frontotemporal Dementia” (P01-AG17586), which includes longitudinal clinical,
neuropsychological, neuroimaging, and genetic data.
The goals of this research proposal will be achieved through three aims:
Aim 1. Examine longitudinal changes in subtypes of apathy in bvFTD compared
to NC.
H1: Based on preliminary longitudinal data, I hypothesize that apathy will worsen
in bvFTD, and that decline will be restricted to the subtype of initial
impairment.
Aim 2. Determine the effect of environmental factors (education, occupation, and
leisure activities) and genetic factors (ApoE status and tau haplotype) as moderators of
annualized rate of change in apathy subtypes.
H1: I hypothesize slowed annualized worsening in apathy in bvFTD individuals
with higher education and occupational attainment and greater leisure
activities.
H2: A more rapid rate of worsening in apathy will be associated with the presence
of ApoE e4 allele and tau H1H1 haplotype in bvFTD.
Aim 3. Relate changes in apathy subtypes in bvFTD to annualized grey matter
thinning and reduced FA on DT imaging studies of white matter; and I will explore the
impact of moderating environmental and genetic factors on rates of grey matter and white
matter change in anatomic structures related to each apathy subtype.
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H1: Change in each bvFTD apathy subtype will be related to progressive grey
matter thinning of specific frontal brain regions and to reduction in FA in
related white matter tracts.
The results from this proposed research will improve understanding of apathy by
providing insights into mechanisms of longitudinal decline and neural compensation.
Optimized interventions for apathy can be designed based on an understanding of these
mechanisms. For example, knowledge of the progression of apathy will give direction for
designing tailored interventions that target problems with initiation, planning, and
motivation, and the optimal timing of their implementation. This work will also allow us
to assess the effectiveness of these interventions based on a comparison with the natural
trajectory of change in bvFTD-related apathy. This work supports the National Institute
of Nursing Research strategic plan and will further my career goal to become an
independent researcher.
Significance
Apathy is extraordinarily common in ND, contributing to poor patient and
caregiver outcomes. Deficits observed in apathetic persons, such as poor planning, poor
motivation, and inability to initiate even the simplest self-care activities, contribute to
deteriorating function and greatly reduced quality of life (Pedersen, Alves, et al., 2009).
Apathy is also associated with other undesirable features, such as poor insight and
impaired cognitive performance (Chase, 2011; Ishii et al., 2009; Pedersen, Alves, et al.,
2009; Pluck & Brown, 2002). These features have strong implications for noncompliance
with therapeutic interventions and further exacerbate disability (Chow, Pio, & Rockwood,
2011). Furthermore, apathy appears to be an independent predictor of earlier risk for
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mortality (Brown & Pluck, 2000; Holtta et al., 2012; Vilalta-Franch et al., 2013). The
societal costs associated with caring for people with ND are enormous. The annual global
burden cost of dementia is estimated at $315 billion (Dartigues, 2009). Long-term care is
a significant driver of costs and rates of institutionalization are higher in apathetic
persons because of the significant strain placed on caregivers (Bakker et al., 2012).
Caring for a person with apathy is extremely challenging. The physical and
emotional demands associated with the need to perform the simplest activities for those
with apathy are profound, and high levels of depression, burden, and stress are reported
in caregivers of apathetic persons (Chio et al., 2010; Massimo et al., 2009). Caregivers
misinterpret apathy as a sign of volitional opposition and poor cooperation (Bakker et al.,
2012; Massimo, Evans, et al., 2013), leading to dissatisfaction with caregiving (Landes et
al., 2001). Thus, it is important to optimize management of apathy. Additionally,
caregivers often want to know what to expect behaviorally from the patient over the
course of their disease (Chow et al., 2012). Insight into the trajectory of apathetic
behavior is important to prepare caregivers for the changes in the affected person.
Findings from this study will be used to inform caregivers about what to anticipate as the
disease progresses. Prognostic information can be used as a decision aid to determine
resources for support.
Currently there are no effective treatments for apathy because of a poor
understanding of the mechanisms underlying this condition. Treatments for apathy can
best be developed in a context where behavioral and anatomic substrates of apathy are
understood. My preliminary dissertation work shows that there are distinct subtypes of
apathy associated with distinct anatomic substrates (Massimo, Evans, Morgan, Powers,
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Grossman, 2012; Massimo, Morgan et al., 2012). An approach accepted for a wide
variety of circumstances to manage apathy, thus, appears to be inappropriate, and tailored
interventions focusing on a specific apathy subtype are more likely to be successful.
Researchers assume that apathy worsens over time (Chow et al., 2012; Turro-Garriga et
al., 2009), yet do not know if these distinct apathy subtypes persist or change
longitudinally. Knowledge of the natural history of apathy is essential in the development
of treatment trials for apathy. This knowledge will contribute critical information to the
design of interventions and inform selection of end-points in treatment trials. In the
proposed work, I will examine how persons with apathy worsen over time (Aim 1) and
identify the influence of environmental, genetic (Aim 2) and anatomic (Aim 3) factors on
the rate of change in apathetic persons. The proposed work will fill a crucial gap and will
be used to develop treatment strategies and evaluate the effectiveness of tailored
interventions.
Conceptual framework. Disturbances of GDB in ND represent a significant
problem that is understudied. In neuroscience, GDB is used to operationalize a broad spectrum
of purposeful actions and their determinants (Brown & Pluck, 2000). GDB is related to the
belief that when action a is taken, x may be obtained as a result. The GDB model has been
proposed to improve understanding of the mechanisms that contribute to the loss of selfinitiated action (Levy & Dubois, 2006); a behavior referred to as “apathy.” According to the
model, three processes—initiation, planning, and motivation—influence the intention to act.
Apathy arises when any one of these three processes is impaired (Massimo, Evans et al. 2012;
Massimo, Morgan et al., 2012).
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These three GDB processes map onto three distinct brain regions that work
together in a large-scale neural network associated with apathy. In particular, three
functional neuroanatomic loops underlying GDB in the frontal area (anterior cingulate
circuit, dorsolateral prefrontal circuit, orbitofrontal circuit) appear to capture the
information from internal and external environments needed for GDBs and possible
actions to be performed. Each circuit is functionally separate in supporting initiation,
planning, and motivation, but interacts with the others to mediate overall GDB. Previous
imaging studies in persons without apathy, and my dissertation data on apathetic persons,
suggest that poor initiation is related to ACC disease, (Kotchoubey et al., 2003; Reijnders
et al., 2010), poor planning is related to disease in dlPFC (Kaller et al., 2011; Unterrainer,
Rahm, Kaller, Leonhart, et al., 2004; van den Heuvel et al., 2005), and reduced
motivation is related to disease in OFC (Diekhof et al., 2011; Sescousse et al., 2010). A
specific process of GDB suffers when one of these frontal areas is compromised,
resulting in apathetic behavior. The proposed research will extend my cross-sectional
dissertation data. First, I will study longitudinal changes in behavior and neuroanatomy
following an impairment of each process of GDB. Second, I will examine the influence
of environmental, genetic, and anatomic factors. A more complete understanding of
apathy will lead to the development of treatments for persons with specific subtypes of
apathy.
Few studies have examined longitudinal decline in bvFTD, a disorder of social
comportment and executive dysfunction related to frontal and temporal degeneration.
Researchers previously reported that neuropsychological impairments in bvFTD remain
distinct over the duration of illness rather than converging in a common undifferentiated
	
  

87
state (Libon et al., 2009). This outcome suggests the brain is highly organized around
specific cognitive functions involving large-scale neural networks. These neural networks
allow individuals to implement compensatory cognitive strategies, thereby maintaining
relatively distinct patterns of impairment well into the disease course (Gigi, Babai,
Penker, Hendler, & Korczyn, 2010). Compensatory brain-reserve mechanisms have been
assessed in only two studies of bvFTD, revealing that reserve mechanisms may be
moderated by factors such as education, occupation, and leisure activities (Borroni et al.,
2009; Y. Liu et al., 2012; Premi et al., 2012; Stern, 2006). Moreover, genetic factors such
as ApoE status and tau haplotype may influence the presence of neuropsychiatric
symptoms (Panza et al., 2012), including apathy (D’Onofrio et al., 2011; Monastero et al.,
2006) and genetic markers such as the presence of the e4 allele have been associated with
faster decline in ND, although this has not been assessed in bvFTD. This research
proposes to examine the influence of environmental factors and genetics on a common
neuropsychiatric syndrome in well-characterized persons with bvFTD to gain a better
understanding of reserve mechanisms and their relationship to behavioral functions such
as apathy to determine who may be “at risk” for faster decline. Finally, brain atrophy is
progressive in a small number of bvFTD studies, (Frings et al., 2012; Gordon et al., 2010;
Whitwell et al., 2008) but the neuroanatomic basis for longitudinal worsening of apathy
has not been examined.
Preliminary studies.
Although several apathy assessment tools exist for the cognitively impaired
population, current instruments such as the NPI are ineffective in identifying subtypes of
apathy (Chow et al., 2009) and may be confounded by caregiver stress (Boyer, Novella,
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Morrone, Jolly, & Blanchard, 2004). Moreover, caregiver-completed surveys do not
assess apathy directly through patient performance. Therefore, as part of my dissertation
work, I developed the PACT, a novel behavioral instrument, based on the GDB model, a
review of experimental paradigms in the scientific literature and clinical observations
(Elliott et al. 2010; Jenkins et al., 2000; Ruh et al., 2010). PACT is used to capture
subtypes of apathy based on impairments in GDB (initiation, planning, and motivation).
A trial begins with a start key depressed. In response to a signal, RT1 is measured when a
participant lifts their finger from the start key; RT2 is the time needed to depress the
target key. Total latency is the sum of RT1 and RT2. Initiation is assessed by measuring
RT1 to a single visual stimulus. To measure the planning component of GDB, two levels
of task difficulty are assessed. To assess motivation, the “simple” planning level is
repeated with a monetary incentive (reward and penalty conditions) using a point system
of “monetary units.” Three scores (see Table 13) are generated from these times in the
conditions described below for the proposed analysis. Below is a detailed description of
the PACT.
Table 13
Scores Generated from the PACT
Score

Measure

Initiation

Reaction Time 1 in initiation condition

Planning

Total latency in “complex” planning level minus Total latency in “simple” planning
level

Motivation

Total latency in reward or penalty condition minus Total latency in “simple” level from
Planning condition
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Preliminary Study 1. My dissertation work examined performance on the PACT
for 19 persons with bvFTD (see Table 13). Participants with an initiation impairment
(N = 5/19) demonstrated significantly slowed time to initiate a response (RT1). Imaging
data showed atrophy in the ACC in this group (see Figure 4, Panel B blue). The planning
impaired group (N = 8/19) had significantly slowed latencies and made errors on the
complex measure of the PACT. Imaging data showed dlPFC atrophy in this group (see
Figure 4, Panel A green). Participants in the third group with impaired motivation
(N = 6/19) were not motivated to perform faster in response to the penalty condition in
the PACT. This group showed significant atrophy in OFC (see Figure 4, Panel A yellow).

Figure 4. Significant regressions of apathy subtypes using PACT measures.
Blue = initiation (anterior cingulate cortex); Green = planning (dorsolateral prefrontal
cortex); Yellow = motivation (orbitalfrontal cortex).
Preliminary Study 2. I collected longitudinal data (mean follow up = 12months)
in 7 bvFTD participants (see Figure 5). Two participants had initiation subtype at Time 1.
Both participants showed more slowing on the initiation measure at Time 2 (slowed by an
average of 162.71msec), but not on the planning or motivation measure (see Figure 5,
Panel A). Three participants met criteria for the planning subtype at Time 1. Times
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slowed for two of three participants (by an average of 108.60msec) on the planning
measure, but not on the initiation or motivation measure (see Figure 5, Panel B). Two
participants met criteria for the motivation subtype at Time 1. At Time 2, only one
participant had additional slowing (555.15msec) on the motivation measure of the PACT.
There were no additional worsening on initiation or planning measures (see Figure 5,
Panel C). In sum, five of seven participants showed worsening that was restricted to the
domain of initial impairment. Two of the seven participants mentioned above did not
show slowing at Time 2. It is possible that these participants have cognitive reserve that
slows the rate of apathy worsening, and I will examine this factor in the proposed study.

Figure 5. Longitudinal worsening in apathy subtypes on PACT measures.
Preliminary Study 3. To explore the effect of cognitive reserve on the
longitudinal trajectory of bvFTD, I performed a retrospective chart review of autopsy
confirmed bvFTD (n = 63). I found that environmental factors like higher occupational
attainment, a proxy for cognitive reserve, were associated with longer survival time in
bvFTD (F = 6.31, p = .0006) (Massimo et al., 2013). In the proposed study, I will
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examine the moderating effect of cognitive reserve on annualized rate of change in the
profile of apathy subtypes.
Research Strategy
A longitudinal case-control research design will be employed to conduct this
study. I chose to compare normal and diseased populations (bvFTD) to elucidate
mechanisms contributing to apathy subtypes. I focus particularly on bvFTD because
apathy is very common in this condition and my dissertation data demonstrated the
presence of each apathy subtype in bvFTD. These individuals do not have physical
limitations that can confound the quantitative assessment of reduced GDB, and have no
language or visuospatial deficits that can potentially limit the interpretation of bvFTD
patient performance during the study. I have the opportunity to integrate my aims and
instruments to collect prospective data on NC and bvFTD participants, as they are newly
enrolled in the cosponsor’s ongoing study, “Cognitive and Neural Impairment in
Frontotemporal Dementia” (P01-AG017586, PI: Virginia Lee, PhD; Clinical Core
Leader: Murray Grossman, MD). The purpose of Dr. Grossman’s longitudinal study is to
collect neuropsychological, neuroimaging, cerebrospinal fluid and genetic data to better
understand the neural basis of impairments in this population, and relate these data to
findings at autopsy. Potential participants are recruited from Dr. Grossman’s FTD clinic
(University of Pennsylvania Center for Frontotemporal Degeneration) in Philadelphia,
PA. Consented participants are assessed at baseline and then 6–12 months following
baseline (see Table 14). Qualifying individuals are invited to enroll. All participants meet
enrollment criteria listed in Table 15.
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Table 14
Schedule of Data Collection
Time 1
initial visit
(Day 1–2)

Clinical diagnosis and demographics
Mini-Mental State Exam
Neuropsychiatric Inventory
Geriatric Depression Scale Short Form
Genetic Data
Neuroimaging
Philadelphia Apathy Computerized Test
Lifetime of Experiences Questionnaire

Time 2
follow-up visit
(6–12 months after
initial visit)

Mini-Mental State Exam
Neuropsychiatric Inventory
Geriatric Depression Scale Short Form
Neuroimaging
Philadelphia Apathy Computerized Test

I will have full access to these data, including neuroimaging and genetic data, for
my own analyses. The proposed study extends the parent study by prospectively
collecting the PACT and Lifetime of Experiences Questionnaire (LEQ) for eligible
participants coinciding with the first two data-collection points (Times 1 and 2). Table 14
explicates the data-collection schedule for each participant; measures added for the
proposed study are bolded. Currently 54 participants with bvFTD are being followed
longitudinally and we have successfully collected full sets of multimodal data
(neuropsychology, DNA, grey matter imaging, and white matter imaging) for 43 of these.
The setting is a reliable source of well-characterized clinical patients because four new
bvFTD patients are diagnosed each month and > 80% of these patients agree to
participate in Dr. Grossman’s research program (see Table 15, Enrollment Criteria for
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Proposed Study). NCs are recruited from the surrounding community and screened prior
to entry in the parent study.
Table 15
Enrollment Criteria for the Proposed Study
Inclusion

Exclusion

Individuals diagnosed with bvFTD (Rascovsky
et al., 2011) or NC

Persons with other neurologic conditions such as stroke
or hydrocephalus, primary psychiatric disorder such as
depression of psychosis, or systemic illness that could
interfere with cognitive functioning.

Mild impairment (measured by Mini-Mental
State Exam ≥ 20) at initial visit

Mini-Mental State Exam ≤ 19 to exclude moderate or
severe dementia to minimize confounding factors
related to severe cognitive impairment.

Participants who are not depressed as
determined by Geriatric Depression Scale Short
Form score of ≤5 at initial visit.

Individuals with depression (Geriatric Depression
Scale-Short Form score > 5) are excluded because
depression is confused with apathy and can confound
interpretation of the data. I will exclude participants in
the rare event that participants become depressed
during follow up.

Modest doses of selective serotonin reuptake
inhibitors or antipsychotic medication may be
needed for clinical management, and thus are
allowed. Moreover, a stable dose (no change
during follow-up study period) is necessary to
minimize potential confounding effects because
these medications can contribute to apathy
(Benoit et al., 2008).

Participants taking regular doses of benzodiazepines
and other soporific medications will be excluded
because of their sedative effects.

A reliable caregiver who has frequent contact
with the participant (> 3 times/week for ≥ 1
hour).

Participants who do not have caregiver contact.
Frequent contact with patient is needed to accurately
rate the patient’s behavior, because patients with
bvFTD often have poor insight into their own deficits
(Massimo, Libon et al., 2013).

Speak and understand English to complete the
questionnaires.

Insufficient English to complete questionnaires.

In Aim 1, a standard apathy scale from the NPI will be administered to identify
participants with apathy. The PACT will be administered to ascertain initiation, planning,
and motivation subtypes of apathy in bvFTD. The PACT will be collected again 6–12
months after the initial visit to examine longitudinal change. I will specifically monitor
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whether participants with all subtypes of apathy, regardless of their initial presentation,
maintain their distinct subtype profile of apathy longitudinally or accumulate additional
subtype features to converge on a single apathy phenotype over time.
In Aim 2, potential moderating environmental factors (education, occupation, and
leisure activities) and genetic factors (ApoE status and tau haplotype) will be related to
changes in apathy subtypes over time. From the perspective of the model of longitudinal
change known as “cognitive reserve,” factors such as education, occupation, and leisure
activities may moderate the rate of longitudinal decline (Bartres-Faz & Arenaza-Urquijo,
2011). Thus, I propose to monitor the ways these environmental and genetic factors
moderate the rates of clinical progression (Stern, 2002). Importantly, this knowledge will
provide insight into potential responses of participants to planned cognitive interventions
for apathy (Simon, Yokomizo, & Bottino, 2012).
In Aim 3, MRI obtained at initial and follow-up assessments in apathetic
participants will be compared to NC, and regression analyses will relate apathy subtype
scores (see Table 13) to cortical thinning and FA of white matter tractography. Biological
factors such as grey matter volume and white matter tractography must be considered to
understand the neuroanatomic basis of change in apathy subtypes. During longitudinal
monitoring of apathy, progression restricted to a specific subtype should continue to
involve primarily a specific neuroanatomic circuit; by comparison, progression involving
additional apathy subtypes may incorporate additional disease involving other brain
regions associated with apathy and/or white matter tracts. I will also explore whether
environmental and genetic factors impact longitudinal MRI changes in areas related to
apathy subtypes.
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Instrumentation for Aim 1: Examine longitudinal changes in subtypes of
apathy.
The PACT is a novel, quantitatively rigorous computerized RT test designed to
quantify each GDB process. In my preliminary dissertation data, the PACT is able to
identify apathy subtypes according to distinct behavioral response patterns (Massimo,
Evans et al., 2012; Massimo, Morgan et al., 2012). In all conditions, a trial begins when
the participant depresses a computer “start” key with one finger. The PACT measures RT
to lift this finger from the start key in response to a signal (RT1) and then RT to depress
the target key (RT2).
Initiation refers to one’s ability to self-generate or activate actions (Levy &
Dubois, 2006). In the simplest condition designed to measure initiation, the participant
begins a trial by depressing the start key, then a central stimulus on the computer screen
appears. A fixed central target key must be depressed in response to this stimulus; the
stimulus occurs on average 1,250msec (range 500–2000msec) after depressing the start
key. Initiation is assessed by measuring RT1.
Planning refers to the ability to elaborate plans of action (Levy & Dubois, 2006).
In the second condition, designed to assess the planning process of GDB, two levels of
task difficulty are assessed. In the first, “simple” level, after depressing the start key,
participants are signaled by randomly-ordered lateralized visual stimuli to press a left or
right target key (stimulus appears on the left, then go left; stimulus appears on right, then
go right). In the second, “complex” level, one of two lateralized keys is pressed
contingent on the combination of patterns in a central visual stimulus (stimulus appears
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on the left, then go left; stimulus appears on right, then go right). Planning is assessed by
measuring the RT difference between these two levels of difficulty.
Motivation refers to the ability to associate affective signals (positive or negative)
with value in order to perform actions (Levy & Dubois, 2006). In the third condition
designed to assess motivation, the “simple” level from the planning condition is repeated
with an explicit monetary incentive using a point system (monetary units) to reward
participants for responding correctly and more rapidly. Participants receive feedback
about their response speed after each trial on the computer screen. I also assess the
sensitivity to negative consequence by having a “penalty” condition, where participants
are given monetary units at the beginning of each task, and monetary units are taken
away if they do not respond correctly and more rapidly. (Unbeknownst to participants, all
receive the same final amount for participation by adjusting the dollar value of a
monetary unit.)
I obtain 48 trials during each condition. A practice block precedes each
experimental condition where participants get instructions on the task and 12 practice
trials. The PACT measures RT1, RT2, total latency (RT1 + RT2) and errors. In our
experience, the PACT takes approximately 45 minutes to complete.
Instrumentation for Aim 2: Determine the effect of environmental factors
(education, occupation, and leisure activities) and genetic factors (ApoE status and
tau haplotype) as moderators of annualized rate of change in the profile of apathy
subtypes in bvFTD.
Environmental factors. The LEQ (Bartres-Faz & Arenaza-Urquijo, 2011) is a
reliable and valid instrument that assesses cognitive lifestyle, a proxy for cognitive
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reserve. The LEQ will be obtained by interviewing a knowledgeable informant for
educational, occupational, and leisure activities that are protective against cognitive
decline. The LEQ consists of 42 items constructed around two dimensions: three life
stages (young, mid, and late adulthood) and specific versus nonspecific mental activity in
each stage. Scores are calculated for each stage and then summed for a total LEQ score.
Higher scores indicate higher lifetime mental activity. The LEQ has an overall internal
consistency of .66 and test–retest reliability of .98, and it discriminates between older
adults with high and low mental-activity levels. Healthy older adults with higher LEQ
scores have shown less cognitive decline over 18 months than those with low scores,
independent of covariates (Bartres-Faz & Arenaza-Urquijo, 2011).
Genetic factors. DNA is extracted from frozen blood using a previously reported
procedure (Van Deerlin et al., 2010). DNA samples will be evaluated for purity by
spectrophotometric analysis (NanoDrop) and for degradation by 1% agarose gel
electrophoresis (Invitrogen). Genetic analysis for bvFTD includes sequence analysis of
ApoE genotype and tau haplotype. ApoE genotyping will be performed by Polymerase
Chain Reaction-Restriction Fragment Length Polymorphism. Tau haplotypes will be
determined by either DNA sequence analysis or by Polymerase Chain ReactionRestriction Fragment Length Polymorphism of Exon 9 using the following intronic
primers: forward 5’acctgcctaacccagtggtg-3’ and reverse 5’gaggggactggggtgttatg- 3’. The
amplified fragment will be digested with HpaII and HpyCH4IV and the resulting
fragments analyzed by agarose gel electrophoresis to determine the haplotype based on
three known polymorphisms of Exon 9 that segregate with the known major haplotypes.
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Instrumentation for Aim 3: Relate changes in apathy subtypes in bvFTD to
annualized grey matter thinning and reduced FA on DT imaging studies of white
matter tractography.
Volumetric MRI. T1-weighted MRI scans will be collected using a researchdedicated Siemens Trio 3.0T scanner with 1-mm slice thickness, in-plane resolution
= .9766 x .9766, and a 195 x 256 matrix using an magnetization-prepared 180 degrees
radio-frequency pulses and rapid gradient-echo (MPRAGE) protocol (TR = 1,620ms, TE
= 3ms, flip angle = 15°).
Diffusion weighted image (DWI). DWI images are collected using the following
parameters: FOV = 240mm; matrix size = 128 x 128; number of slices = 70; imaging
resolution = 1.9 x 1.9 x 2 mm; TR = 8,000ms; TE = 82ms; fat saturation. In total, 34
volumes will be acquired per subject, four volumes without diffusion weighting (b = 0
s/mm2) interleaved within 30 volumes with diffusion weighting (b = 1,000s/mm2) along
30 noncollinear directions.
Analyses.
Analyses Aim 1: Examine longitudinal changes in subtypes of apathy. The
overall sample will be described demographically and according to continuous measures of the
PACT using means, standard deviations, median, and interquartile ranges. Additionally the
sample will be described according to the apathetic subtype of initiation, planning, and
motivation (see criteria below) using means, standard deviations, and z-scores. I established the
criteria shown in Table 16 to partition participants into subtypes using PACT observations
(Elliott et al. 2010; Jenkins et al., 2000; Ruh et al., 2010).
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Table 16
Criteria for Apathy Subtypes
Subtype

Criteria

Initiation

Significantly slow RT1 in initiation condition; does not have slowed latencies for
“complex” level of planning condition; able to improve performance on the “simple”
planning level in response to “reward” or “penalty.”

Planning

Significantly greater slowing on the “complex” planning level compared to the “simple”
planning level; does not have slowed initiation for all conditions; able to improve
performance on the “simple” planning level in response to “reward” or “penalty.”

Motivation

Fails to respond to “reward” or “penalty” motivators in “simple” level of planning
condition; does not have slowed initiation for all conditions; does not have slowed
latencies for “complex” level of planning condition.

Individual z-scores will be used to define subtypes. These will be based on the
entire patient population. Participants will be designated as a specific subtype if the
z-score is > 1.96 for one condition, but within the range of the remainder of the
population (i.e., z-score 1.96) for the remainder of the conditions. I will use a linear
mixed-effects model (Laird & Ware, 1982) to assess longitudinal change in each subtype.
Linear mixed-effects models account for within-subject correlations over time and
accommodate both variable length of follow-up for different subjects and variation in the
interval between assessments. In the analysis, the intercept and regression coefficients for
the follow-up time will be treated as random effects, such that each individual would
have a unique intercept and regression coefficient for the follow-up time. Population
mean coefficients for the follow-up time will be obtained by averaging the participants’
specific regression coefficients for follow-up time. The population mean regression
coefficient for the follow-up time estimates the annual change in PACT scores over time
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and accounts for differences in baseline PACT scores. I will also confirm subtype
worsening relative to NC.
Analyses Aim 2: Determine the effect of environmental factors (education,
occupational attainment, and leisure activities) and genetic factors (ApoE status and
tau haplotype) as modulators of annualized rate of change in the profile of apathy
subtypes in bvFTD. Environmental factors such as education, occupation, and leisure
activities data will be scored according to the LEQ, as described above. The patient group will
be dichotomized based on the following genotypes: (a) ApoE e4 carrier versus not; (b)
microtubule-associated protein tau genotype H1/H1 versus not. Linear mixed-effects models
will be used to test for associations between environmental factors, different genotypes and
changes in apathy subtypes.
Analyses Aim 3: Relate changes in apathy subtypes in bvFTD to annualized
grey matter thinning and reduced FA on DT imaging studies of white matter
tractography.
Volumetric MRI. High-resolution volumetric (1mm3) images will be segmented
and normalized to a common space using Pipedream and ANTs (Avants, Tustison, Song,
et al., 2011; Avants et al., 2008), as previously reported. Briefly, this procedure provides
the newest ideas and most current features (Harris, Adams, Zubatsky, & White, 2011):
unbiased diffeomorphic and symmetric registration of MRI volumes into local template
space. MRI volumes are then segmented into three tissue classes using probabilistic
information and template priors (Avants, Tustison, Wu, et al., 2011) and from these
images I will compute grey matter density and cortical thickness (Das et al., 2009). I will
use the multiple-regression module in SPM8 to identify the relationship between
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performance on each PACT score (see Table 13) and cortical thinning. To constrain the
interpretation of the regression analysis to areas of known disease in bvFTD, I will use an
atrophy mask generated from a t-test contrast of all apathetic bvFTD participants relative
to NC. I will also evaluate atrophy in each apathy subtype defined according to
behavioral performance on the PACT. I will evaluate longitudinal change in grey matter
by generating a single volume reflecting longitudinal change (Time 2 - Time 1/months),
and compare this to longitudinal change in NC. The regression module in SPM8 will be
used to relate longitudinal imaging change to change in PACT scores. To determine the
relative contribution to the variance of environmental and genetics factors, I will also
perform a stepwise multiple-regression analysis.
DTI. DWI images will be preprocessed using ANTs (Avants, Tustison, Song, et
al., 2011) and Camino (J. Perry, 2002). Motion and distortion artifacts will be removed
by affine coregistration of each DWI to the unweighted (b = 0) image in the diffusion
imaging sequence. DT will be computed using a linear least squares algorithm
implemented in Camino. The distortion between the participant’s T1 and DT images will
be corrected by registering FA in the DT image to the T1 image. The DT image will be
warped to template space by applying intrasubject (FA - > T1) and intersubject (T1 > template) warps. A general linear-model module in SPM8 will be used to compare FA
in bvFTD to NC. I will calculate mean FA in each apathy subtype defined by behavioral
performance (see Section B.7.1). I will also use logistic regression to evaluate the
relationship between apathy subtypes and FA. I will evaluate longitudinal change in FA
by generating a single volume reflecting longitudinal change (Time 2 - Time 1/months).
The regression module in SPM8 will be used to relate longitudinal imaging change to
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change in PACT scores. To determine the contribution of environmental and genetic
factors, I will perform stepwise multiple-regression analysis.
Power analyses. Sample-size estimates and power calculations are based on the
minimum detectable slope (rate of decline) difference between two groups (e.g., NC and
bvFTD) over time using a mixed-effect model, with an α = .05. I assume moderate
correlations between repeated measures (r = .5) and one follow-up after baseline. Table
17 lists sample size needed per group to detect a slope difference between two groups.
With 16 participants per group, we will have 80% power to detect a slope difference of
1.0 SD of an outcome measure (e.g., PACT scores). The detectable effect size (1.0 SD) is
larger than what was observed (0.3 SD) in pilot data. However, the current study allows
me to generate important pilot data for a larger scale study in the future. For the imaging
studies, a minimum of 20 participants are required in each group to detect a 1mm
(equivalent to 1 voxel) change at the p < .05 (corrected) level with a beta of 0.15
(power = .85). The final sample size, accounting for a 10% attrition rate will be 44
participants (NC and bvFTD).
Table 17
Sample Size to Detect Difference Between Two Groups
SD diff

β = 0.8

β = 0.9

0.5

63

84

0.75

28

37

1.0

16

21

1.5

7

9

	
  

103
Potential Challenges
Interpretation and potential problems Aim 1. I predict that the profile of
apathetic subtypes will be maintained over the course of the disease trajectory, (Libon et
al., 2009), although additional deficits may accrue over a longer duration. If I see slowed
RTs for more than one PACT measure in a subtype, I will look for additional evidence
for generalized cognitive worsening using neuropsychological measures (collected by the
cosponsor’s ongoing longitudinal study), as previously reported in my cross-sectional
dissertation study, and covary PACT performance for these general cognitive deficits.
There may not be worsening in a subtype, and this may be due to not enough time
between Time 1 and Time 2. I will also assess cognitive reserve factors that may
minimize or slow worsening (see Aim 2).
Interpretation and potential problems Aim 2. I predict that the rate of change
in apathy will be moderated by environmental and genetic factors. There may be too
much variation in occupation and leisure activity so I may have to categorize these
variables according to level of cognitive stimulation the activity provides, as previously
reported (Foubert-Samier et al., 2012). I expect participants with e4 alleles and H1H1
haplotypes will have faster rates of worsening in apathy than those without these genetic
markers (Di Maria et al., 2010; Morley et al., 2012). If I do not detect an effect on the
trajectory of apathy due to limited impact of genetics on apathy, I will look for additional
evidence of moderating effects in other cognitive domains using longitudinal
neuropsychological (collected under the cosponsor’s ongoing longitudinal study). I may
also look at the influence of the number of e4 alleles on apathy worsening (additive
model) rather than the proposed dominant method (e4 present or not). Rather than
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affecting the slope of decline, factors such as education and leisure activities may delay
the point at which worsening begins; likewise, the presence of genetic risk factors may
hasten the onset of worsening rather than steepen the slope. These alternatives can be
assessed statistically.
Interpretation and potential problems Aim 3. I predict that apathetic
participants will have significant cortical thinning and loss of white matter integrity in the
frontal lobe (Diekhof et al., 2011; Kaller et al., 2011; Kotchoubey et al., 2003; Reijnders
et al., 2010; Sescousse et al., 2010; Unterrainer, Rahm, Kaller, Leonhart, et al., 2004). If
unable to detect longitudinal change in the proposed imaging regression, I will obtain
mean grey matter thickness values at Time 1 and Time 2 and compare with t-tests. I can
also evaluate DTI using tract-specific analysis, which minimizes “crossing-fibers” and
enables the analysis of individual white matter structures (Wimo, Jonsson, Bond, Prince,
& Winblad, 2013). I will also evaluate whether white matter disease is related to grey
matter disease or independent from grey matter disease by investigating the residuals of
white matter atrophy in a linear regression that includes areas of grey matter atrophy as
nuisance covariates, and vice versa.
It is also possible that participants with long disease duration will have diffuse,
nonspecific atrophy, and I propose to examine participants who are mild at initial visit. I
will also evaluate whether disease duration and age contribute to group-level difference
by including these as nuisance covariates. It may be difficult to obtain imaging in some
participants because of time restriction, medical contraindication (e.g., claustrophobia
and pacemakers) and participant preferences. If this is the case, participants will still be
asked to participate in the PACT assessment and I will assess the dataset to ensure those
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who are imaged are representative of the entire data set by performing t-tests to ensure
there are no significant differences between those who are imaged and those who do not
have imaging data.
The MRI may not have been collected on the same day the PACT was
administered; however all images will be collected within 6 months of the PACT. Given
the rate of brain volume change in bvFTD, 6 months is a widely accepted timeframe
(Whitwell et al., 2008). Despite these caveats, the results from this research will extend
my dissertation work by providing an understanding of the trajectory of apathy as well as
the identification of factors that moderate the progression of this devastating
neuropsychiatric symptom. With this knowledge, tailored interventions that target
problems with initiation, planning, and motivation can be appropriately designed and
implemented.
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CHAPTER 5: DISCUSSION
Introduction
Apathy, a reduction in GDB (Levy & Dubois, 2006), profoundly limits a person’s
ability to engage in self-care activities. Apathy affects 90% of people with bvFTD (DiehlSchmid et al., 2006), a common cause of early onset ND. Researchers hypothesized that
apathy emerges where there is dysfunction at the level of GDB (Levy & Dubois, 2006).
Therefore, I proposed to use the GDB model to examine the brain-behavior relationships
underlying apathy in bvFTD. Specifically, I conducted an empirical study that quantified
difficulty with each component of GDB using a novel computerized RT test, examined
the distinct prefrontal neuroanatomical substrates of these impairments in an apathetic
bvFTD sample using regression, and related specific apathetic behaviors to grey matter
atrophy and white matter integrity, quantified by MRI. This study used a novel RT test
and neuroimaging to examine three dissociable behavioral and neuroanatomical
components of GDB—initiation, planning, and motivation—in a sample of 20 apathetic
adults with bvFTD and 17 normal older adults. Impairment in each of these components
was associated with selective disruption of a large-scale neuroanatomic network
underlying GDB. Specifically, impaired initiation was related to disease in the ACC,
impaired planning was related to disease in the dlPFC and impaired motivation was
related to disease in the OFC. Moreover, some participants with bvFTD were found to
have specific subtypes of apathy, depending on the impaired GDB mechanism, whereas
others had more global impairments. Together, these findings demonstrate that apathy is
not simply a unitary phenomenon, but rather has multiple components related to
impairments in GDB. In this chapter, I elucidate these findings: (a) how initiation,
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planning, and motivation are supported by a large-scale neural network constituting the
neuroanatomic basis for GDB, including distinct grey matter regions in the frontal lobe
and related white matter projections, and (b) how, when compromised, impairments in
these mechanisms contribute to apathy in bvFTD. This discussion concludes with
implications for clinical practice and social neuroscience research.
Summary and Discussion of Principal Findings
GDB is supported by a large-scale neural network in distinct specific
portions of the prefrontal cortex (AIM 1, see Chapter 2). The integration of three
processes that influence the intention to act are central to the model of GDB is (Levy &
Dubois, 2006). Initiation refers to one’s ability to self-generate or activate actions.
Planning is the ability to elaborate plans of action. Motivation refers to the ability to
associate affective signals (positive or negative) with value in order to perform actions. I
found that apathetic bvFTD participants are impaired in one or more of these three
processes. Further, impairments in these three GDB processes were associated with
disease in three distinct frontal grey matter regions and in white matter projections
between these regions and other brain areas.
I found that difficulty in initiating a behavior is related to reduced grey matter in the
ACC and white matter tracts including the cingulum (H1). Considerable published work has
suggested that the ACC is important for initiating a behavior (Tekin & Cummings, 2002),
and the ACC has previously been implicated in processes that influence action initiation
in studies with healthy adults (Mulert et al., 2003). For example, fMRI studies have
demonstrated the role of the ACC in processing “action”-related signals such as
movement selection (e.g., simple finger tapping) and timing of movement initiation (e.g.,
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selecting the moment of when; Hoffstaedter, Grefkes, Caspers, et al., 2013; Hoffstaedter,
Grefkes, Zilles, & Eickhoff, 2013). Additionally, the ACC is functionally linked to
important motor systems such as premotor areas and the basal ganglia, suggesting a core
network of brain structures, important for implementation of intentional motor control
(Beckmann, Johansen-Berg, & Rushworth, 2009; Hoffstaedter, Grefkes, Caspers, et al.,
2013).
The ACC is also implicated in initiation difficulty in those with frontal-lobe injury.
For example, the akinetic mute state—a medical term describing patients who tend to sit
quietly in the same position all day without speaking or talking—has been specifically
related to ACC damage (Mega & Cohenour, 1997). The ACC has been well studied in
dementia, and neuroimaging evaluations have linked the ACC region to apathy in various
groups. Specifically, reduced grey matter density in the cingulate gyrus was associated
with apathy in persons with bvFTD (Massimo et al., 2009; Zamboni et al., 2008) and PD
(Reijnders et al., 2010). Previous DTI studies investigating white matter disease and
apathy have shown associations among the three frontal areas important for GDB. That is,
the cingulum has reciprocal connections between ACC and the medial orbitofrontal
region that is important for motivation (Hahn et al., 2013; J. W. Kim et al., 2011; Ota et
al., 2012). In healthy adults, ACC and dlPFC structures work in concert during complex
tasks that require attentional control, and this is likely mediated through the cingulum
(Silton et al., 2010). These prior findings provided support for the notion that disease in
ACC and interruption of projections between ACC and other structures important for
GDB may contribute to apathetic behavior, and were further supported in this study.
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I found that deficits in the planning component of GDB were associated with
atrophy in the dlPFC and reduced FA in related white matter tracts, including SLF and
frontal corona radiata (H2). fMRI studies of healthy adults suggested that the dlPFC
supports planning and working memory (Di et al., 2013; Miller & Cohen, 2001). In
addition, some studies demonstrated hemispheric specialization or differential effects of
right and left dlPFC in planning tasks. For example, researchers thought the left dlPFC
analyzes propositional information such as task parameters, whereas the right dlPFC
manipulates and integrates information into a sequence (Huey et al., 2009; Ruh, Rahm,
Unterrainer, Weiller, & Kaller, 2012). Thus, it is likely that patients who suffer from
dysfunction in these circuits fail to elaborate, manipulate, and integrate important
information needed for behavior that is goal directed. Studies have suggested a
relationship between apathy and poor executive function in bvFTD (Eslinger et al., 2012;
Zamboni et al., 2008). Eslinger and colleagues (2012) found caregiver apathy scores were
significantly correlated with executive-function measures, suggesting that apathy
emanates in part from difficulty manipulating and integrating elements of a plan to
achieve a goal. Imaging studies of persons with FTD and AD have linked apathetic
behavior to atrophy in dlPFC (Massimo et al., 2009; Zamboni et al., 2008). In addition, a
previous study of persons with amnestic mild cognitive impairment revealed a
relationship between reduced FA in the SLF and apathy (Cacciari et al., 2010). The SLF
is a prominent white matter tract interconnecting the frontal, temporal, and parietal lobes;
this tract has been implicated in the integration of these diverse regions involved in
planning (Genova et al., 2013). Thus, my findings are congruent with previous work.
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I found that difficulty with the motivation component of GDB is associated with
atrophy in the OFC and related white matter tracts, including UNC (H3). Evidence from
healthy subject fMRI studies suggests that the OFC plays a role in interpreting value- and
reward-related information (Hare et al., 2010). In particular, evidence suggests that the
medial OFC is more sensitive to reward signals and the lateral OFC is more sensitive to
punishment signals (X. Liu, Hairston, Schrier, & Fan, 2011). Thus, the OFC encodes and
assigns the relative value of reward for future decisions on avoidance or acquisition of the
stimulus (S. I. Kim, 2013). Deficits in processing value and reward have been examined
extensively in persons with FTD because they appear to have early degeneration of this
frontal circuit in comparison to persons with other neurodegenerative conditions
(Rabinovici et al., 2007).
Poor motivation can occur in these individuals because they may have decreased
reactivity to positive “reward” and negative “punishment” signals, thereby making goalselection difficult (Levy & Dubois, 2006). Experimental evidence, however, has
emphasized that persons with bvFTD and other diseases affecting OFC have the greater
difficulty interpreting “punishment” rather than “reward” signals (Grossman et al., 2010;
Noonan, Kolling, Walton, & Rushworth, 2012). Imaging evidence from persons with
bvFTD has emphasized the link between OFC and apathetic behavior (Massimo et al.,
2009). fludeoxyglucose PET brain activity is decreased in OFC in bvFTD patients with
apathetic compared to nonapathetic patients (Peters et al., 2006). Apathy scores from the
NPI have been associated with atrophy in ventromedial frontal regions (Rosen et al.,
2005). UNC is a major tract connecting the anterior temporal lobe with the medial and
lateral prefrontal cortex (Papagno et al., 2011), areas known to be important for GDB
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(Kable & Glimcher, 2007). DTI studies performed in AD and PSP implicated UNC in
apathy (Hahn et al., 2013; Kvickstrom et al., 2011), and my results extend this finding to
bvFTD.
Three subtypes of apathy, based on differentiated impairments in GDB, exist
in bvFTD (AIM 2, see Chapter 3). Consistent with the definition of apathy as the
pathology of GDB, I studied a sample of apathetic bvFTD participants and identified
individuals who demonstrated impairments on one or more components of GDB.
Consider first the failure to initiate behavior, which leads to a subtype of apathy when
processing is unable to generate a signal significant enough to begin a response. The
initiation condition of the PACT assessed this GDB component quantitatively by
measuring latency to initiate a movement in response to a visual signal. I found that some
apathetic bvFTD participants were significantly impaired only on this component of
GDB (H1).
Initiation difficulty, however, was not the only basis for apathetic behavior. The
ability to execute an action is also highly dependent on the cognitive processes needed to
plan, organize, and carry out goals. Apathy related to “cognitive inertia” can result from
impairments in executive functions such as planning, working memory, and taskswitching (Burgess, 2000; Levy & DuBois, 2006). I assessed two levels of task difficulty
in the planning condition of the PACT. In the first level (simple planning condition), after
depressing the start key, participants were signaled by randomly-ordered lateralized
visual stimuli to press a left or right target key. In the second, more complex level, one of
two lateralized keys were pressed, contingent on the combination of patterns in a central
visual stimulus (blue and horizontal stripes go left, orange and vertical stripes go right). I
	
  

112
found that some apathetic participants were significantly impaired only on the planning
condition (H2). Moreover, poor planning was the most prevalent single component of
GDB found to be impaired in this bvFTD sample. This is not surprising, given that a
dysexecutive neuropsychological profile is a common finding in bvFTD (Rascovsky et al.,
2011). Another component of GDB is motivation, that is, responsiveness to external and
internal drives that may be perceived as positive or negative. Apathy may result from a
lack of responsiveness to reward or risk, thereby making goal-selection difficult (Levy &
Dubois, 2006; Rosen et al., 2002; Schultz et al., 2000). Likewise, reduced ability to
assess and interpret consequences of actions, whether positive or negative, can limit
motivation (Zamboni et al., 2008). Patients with bvFTD typically have a greater desire
for certain rewards such as money, but tend to show insensitivity to negative
consequences (Grossman et al., 2010; D. C. Perry et al., 2013). Therefore, I used a
penalty condition (negative consequence) to assess impaired motivation. I found that
participants performed faster on the simple reward condition (compared to the simple
condition without incentive), suggesting they were motivated by the monetary incentive.
Their performance pattern did not change, however, when I removed monetary units in
response to not performing faster, suggesting an insensitivity to negative consequences.
In my sample of bvFTD participants, I identified some individuals with single
impairment in the motivational component of GDB (H3). Thus, the results support the
presence of differentiated sources of apathy, including deficits in initiation, planning, and
motivation that work together to limit GDB.
Together, the analyses of Aims 1 and 2 support the model of apathy as a
complex behavioral syndrome comprised of three distinct mechanisms related to
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impairments in GDB, each with its own neuroanatomical basis. Using this model
opens new avenues of approaches to managing or treating apathy. Most researchers of
bvFTD have assumed that apathy is a single, undifferentiated behavioral phenomenon
(Rosen et al., 2005, Zamboni et al., 2008). One early approach proposed defining an
undifferentiated form of apathy as a lack of motivation (Marin, 1990), although lack of
motivation does not appear to be the only mechanism that contributes to apathetic
behavior. Others have suggested that apathy is related to impairment of other single
processes such as difficulty with initiation (Tekin & Cummings, 2002). Subsequently,
investigators proposed to define apathy as “the quantitative reduction of self-generated
voluntary and purposeful behavior” (Levy & Dubois, 2006, 916). The model of GDB
includes initiation, planning, and motivation (Brown & Pluck, 2000), which allow a
person to direct purposeful behavior toward a desirable goal or away from an undesirable
outcome (Geurts & de Wit, 2013). Although each process is necessary to achieve GDB,
my research findings suggest these processes are, in fact, dissociable. For example, I
found that apathetic bvFTD patients are impaired on one or more of the three processes
thought to contribute to GDB: initiation, planning, and motivation. These three GDB
processes were associated with disease in three distinct frontal grey matter regions and in
white matter projections between these regions and other brain areas. Moreover, I found
apathetic participants who demonstrated single deficits in only one of the three
components of GDB. Indeed, apathy arises when any one of these three processes is
impaired. For example, patients who have impairments in executive abilities needed to
carry out plans of action may not find it difficult to initiate GDB or lack motivation, but
their planning impairment may overwhelm their ability to develop plans of action that are
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complex. My findings, thus, suggest that each GDB process is relatively independent and,
when compromised, likely contributes to apathy.
Implications for Practice
This study examined a pathophysiological model of GDB, which revealed three
distinct mechanisms likely contributing to apathy: impairments in initiation, planning,
and motivation. A future goal is to optimize interventions for apathy subtypes based on
an understanding of these mechanisms. The assessment of the efficacy of treatments for
apathy has heretofore been hindered because of methodological failures in trials where
apathetic patients are viewed homogeneously, for example solely as displaying a “lack of
motivation.” I found that lack of motivation is not the only process that contributes to
apathy. Based on my work, future treatments for apathy would more appropriately be
tailored to the specific component(s) of GDB that is (are) compromised in an individual.
Interventions should be explored based on the structural anatomic features of each of the
three impairments in GDB. For example, when apathy emerges in response to planning
difficulties, benefit may be gained from restructuring a complex activity into simple
components for the patient. For patients with impaired goal-selection (motivation),
modifications such as amplified lighting in a room or onto a specific activity or object
may increase the reward potential of the environment (Ishii et al., 2009). Last, MSS—a
therapeutic approach that provides visual, auditory, tactile and olfactory stimulation—
may be helpful for patients with initiation difficulty (Baker et al., 2001). The use of MSS
in a patient with planning difficulty, however, may worsen rather than improve apathy
because it can cause distractibility. To facilitate research, a systemic evaluation of
existing interventions for apathy is warranted, followed by the categorization and testing
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of interventions designed for specific subtypes. These studies are important to improve
patient and caregiver quality of life.
Recognizing and making a reliable diagnosis of apathy is essential to initiate
treatment. Healthcare practitioners may overlook patients with apathy because of their
lack of apparent distress (Butterfield et al., 2010). Although several apathy-assessment
tools exist for the cognitively impaired population, researchers lack agreement on the
interpretability of the data from these measures (Clarke et al., 2011). Traditional
instruments to ascertain the presence of apathy commonly rely on proxy report.
Unfortunately, this approach is subject to caregiver confounds such as burden and strain
that may impact the evaluation. This dissertation study, along with others (Boyer et al.,
2004), has found that this approach is biased by caregiver stress. One goal of the present
study was to identify subtypes of apathy in an objective manner, minimally confounded
by proxy report. This study furthers the research in this area because I used an
empirically-based approach that elucidated mechanisms contributing to apathy. This
work is the first step in the development of an instrument that would be based on
objective, empirical measurements of impairments of each of the components of GDB
that contribute to apathy. Such an instrument would improve on the current instruments
because of its objective basis and would increase the likelihood of detection and targeted
treatment of specific subtypes of apathy.
Implications for Social Neuroscience
I propose, in short, that the syndrome of apathy is complex, consisting of
impairments in at least one GDB process. As discussed above, these processes are largely
independent of each other, rather than sequential or hierarchical, as has been suggested
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by others (Dezfouli & Balleine, 2013; Levy & Dubois, 2006). My findings support the
view that apathy is a conceptually heterogeneous syndrome, explained in part by
underlying dysfunction at the neuroanatomical level. Figure 6 presents an illustration of
my hypothesized model of apathy, adapted from Levy and DuBois (2006).

Figure 6. Model of apathy as the pathology of goal-directed behavior in behavioral
variant frontotemporal degeneration.
Note. Adapted from “Apathy and the Functional Anatomy of the Prefrontal Cortex-Basal
Ganglia Circuits,” by R. Levy & B. Dubois, 2006, Cerebral Cortex, 16, 918.
doi:10.1093/cercor/bhj043
Study Strengths
Although apathy is a significant problem that is commonly observed in persons
with bvFTD and has a pervasive impact on their caregivers, current understanding of
apathy is based on observational data. This dissertation is the first study to examine
apathy using the GDB model to guide direct, empirical assessments of behavior and
interpretation of results. Overwhelmingly, the most common way to assess apathy has been
through caregiver questionnaires. Caregiver surveys, however, do not assess apathy by directly
ascertaining patient performance, thereby limiting their validity and reliability. Moreover,
ascertainment of patient apathy solely from a caregiver’s perspective is likely to be confounded
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by caregiver stress (Boyer et al., 2004). Indeed, I found a correlation between apathy symptom
FxS scores and caregiver-distress scores on the NPI. Currently available instruments, such as
the NPI, are less than optimal because they are also insensitive to subtypes of apathy (Chow et
al., 2009). The PACT was developed as an alternate measure that provides a direct,
independent assessment of GDB components contributing to apathy that is not biased by the
subjectivity of caregiver-rated questionnaires.
The method used in this dissertation, thus, offers several advantages over
traditional, questionnaire-based approaches to measuring apathy because I directly
ascertained participant performance without the intervening factor of a caregiver’s
impression. Moreover, I assessed several different components of GDB that are believed
to contribute to apathy. Although not a primary aim of the study, the study data served to
provide validation for the PACT with a neuroanatomical model of apathy. I used VBM to
quantify significant grey matter changes in this bvFTD sample and I related these
changes to PACT performance. Based on previous literature reports in ND and lesion
studies, I hypothesized that poor initiation was related to ACC disease (Kotchoubey et al.,
2003; Reijnders et al., 2010), poor executive function (planning) was related to disease in
dlPFC (Kaller et al., 2011; Unterrainer, Rahm, Kaller, Ruff, et al., 2004), and reduced
motivation was related to disease in the orbital and medial prefrontal cortex (Diekhof et
al., 2011; Sescousse et al., 2010). These earlier findings were replicated in my
dissertation data. My hypothesized anatomic model of apathy falls in the broad area in
the frontal lobe that I had previously correlated with NPI FxS apathy scores (Massimo et
al., 2009). Moreover, my assessment of white matter disease was the first to examine
apathy in bvFTD comprehensively. The availability of both grey matter and white matter
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neuroimaging data allowed me to investigate a large-scale neural network that subserves
a complex behavior. This allowed me to develop a framework that captured the complex
associations of impaired GDB encompassing the various subtypes of apathy and their
associated neuroanatomic substrates, and to examine the ways the breakdown of this
network can lead to the clinical syndrome of apathy.
Study Limitations
Several potential limitations should be kept in mind when considering these
findings. Although the sample was larger than in prior investigations of apathy, I
nevertheless studied a small number of participants; power in the imaging studies may
not have been sufficient to detect every anatomic region associated with apathy. In
addition, as anticipated, the participant sample was not diverse and querying the database
to find a representative sample did not reveal additional women or diverse racial/ethnic
participants. Because floor effects in performing the planning measure limited variance, I
was forced to use a higher threshold for the grey matter analyses in Chapter 2. In addition,
I had to adjust my planning subtype criteria in Chapter 3. Most participants with
impairments in initiation and/or motivation also had a planning impairment, consistent
with the dysexecutive profile typically seen in bvFTD (Rascovsky et al., 2011). To better
classify participants with impaired planning, I implemented the application of the
planning criteria for those with multiple impairments in a stepwise fashion. That is, I
subjected planning-impaired participants who also had deficits in initiation and/or
motivation to a second level review; I only classified participants who also had greater
slowing on the complex planning condition compared to the simpler planning condition
into the planning-impairment subtype.
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Based on these considerations, however, it will be important in future studies to
make the planning condition less complex by giving participants only two contingencies.
Four participants with an isolated planning subtype were mildly impaired on the
complex-planning condition (mean z-score = 2.52), but their difference score on the
simpler planning condition compared to complex planning condition did not quite attain
significance. Thus, it will be important in the future to study more patients with mild
apathy to better characterize early behavioral changes. Additionally, I studied participants
with mild ND (defined by MMSE score), and it would be valuable to extend assessment
to participants with greater cognitive impairments. It would also be important to follow
participants longitudinally to see if apathetic profiles are maintained throughout the
duration of disease (see Aim 3, Chapter 4). I studied apathy in bvFTD particularly
because it is very common in this condition; these patients do not have physical
limitations that can confound the quantitative assessment of reduced GDB, and there are
no language or visuospatial deficits that can potentially limit the interpretation of
impaired performance. Nevertheless, it is important to investigate GDB in apathetic
participants with other ND, like AD or PD, who also display apathy.
Areas for Further Research
This dissertation research study found that three distinct mechanisms, related to
impairments in GDB, likely contribute to subtypes of apathy in bvFTD. As previously
described, conceptualizing distinct subtypes of apathy may benefit the development of
interventions tailored to mediate each compromised mechanism, but I must first
understand the natural history of these impairments and the biological and environmental
factors that influence the rate of their decline. The identification of factors that moderate
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the clinical expression of disease, in this case apathy, is an important consideration for
identifying persons “at risk” for more rapid decline and optimizing interventions for all
persons with apathy associated with ND. Thus, my next research projects will examine
how GDB impairments in apathetic bvFTD patients worsen over time (Aim 3, see
Chapter 4). I plan to identify the influence of cognitive reserve factors such as
environmental, genetic and anatomic influence on the rate of change in GDB
impairments in apathetic persons with bvFTD. This will help me gain a better
understanding of reserve mechanisms and their relationship to apathy, to determine who
may be “at risk” for faster decline. With support from my Ruth L. Kirschstein National
Research Service Award for Individual Postdoctoral Fellowships (F32; see Appendix B),
this work will fill a crucial gap and will be used to develop treatment strategies and
evaluate the effectiveness of tailored interventions.
A number of participants (40%) were impaired on multiple components of GDB.
Compared to individuals displaying a multicomponent subtype of apathy, those with a
single GDB deficit did not differ by age, disease duration, MMSE or NPI FxS score (all
p > .05), suggesting that I cannot easily attribute variations in apathetic difficulty to
variability in the underlying disease process, but instead can relate them, in part, to
anatomical distribution of disease. Additional work is needed to confirm this with larger
groups of participants.
A questionnaire instrument that measures each component of GDB, quantified by
the PACT, may provide further validation for my hypothesized GDB model. As
previously described, beyond confirming the presence of apathy, current instruments such
as the NPI are ineffective in identifying different subtypes of apathy (Chow et al., 2009).
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In fact, I did not find correlations between PACT scores (individual or composite) with
either NPI caregiver-distress scores or NPI FxS apathy scores. This lack of finding
provides support for the notion that the NPI assesses global apathy whereas the PACT
assesses component of GDB that contribute to apathy.
A necessary step is the development of an instrument that is based on my
empirical measurements of impaired GDB. This type of instrument would increase the
likelihood of detection and treatment of subtypes of apathy and, being specific to each
component of GDB, may invite less respondent bias than do existing more general
measures. Other instrumentation such as neuropsychological measures may also provide
validation for my hypothesized model. I did not find significant correlations between the
neuropsychological data available for my study and initiation and motivation measures
from the PACT. This may be due, in part, to the lack of specificity for initiation and
motivation constructs in currently available measures.
I did observe some overlap across behavioral and neuroanatomical measures. For
example, my grey matter observations suggested that the ACC may contribute to both
initiation and motivation. In fact, post hoc correlation analyses of PACT measures
revealed a significant correlation between initiation and motivation performance
(rho = .78; p < .001). Post hoc correlations, however, are not significant between other
PACT measures (all p > .05 Bonferroni corrected) and I otherwise observed distinct
neuroanatomical regions contributing to components of GDB. It will be important for
future work to identify quantitative measures of initiation and motivation that are not
interdependent.
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This study investigated the neural basis for apathy from a structural
neuroanatomical viewpoint. Although voxel-based morphometry is the most commonly
used approach to examine the anatomical basis of behavioral syndromes in ND, the
measurement of brain activation using functional neuroimaging (fMRI) may be a
complementary way of validating and increasing understanding of the GDB model. My
findings suggest that GDB is supported by a large-scale neural network in distinct
specific portions of the prefrontal cortex. A functional investigation of apathy may
provide additional information regarding how each process of GDB interacts with
another. Other technologies that measure function such as transcranial magnetic
stimulation or actigraphy may be helpful in confirming the interaction of GDB processes.
This can be done by examining distinctive patterns of cortical excitability or locomotive
activity. In sum, apathy is a complex behavioral syndrome and multimodal methods
should be adopted in future research to provide insight into the dynamic interrelationships
between structure and function (Carey & Seitz, 2007).
Conclusion
GDB is a multicomponent process that involves initiation, planning, and
motivation. These three GDB processes map onto three distinct brain regions that work
together in a large-scale neural network. This network captures the information from
internal and external environments needed for GDBs. Each frontal region is functionally
separate in supporting initiation, planning, and motivation, but interacts with the others to
mediate overall GDB. A specific GDB process suffers when one of these frontal areas is
compromised, and is associated with behavior currently referenced as apathy. Presently, apathy
is viewed as a unitary concept. This research has supported the view that apathy is a
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multicomponent phenomenon—a complex behavioral syndrome that emerges when there is
dysfunction in any GDB component. Thus, it is likely that the pathophysiology is not a single
mechanism, but rather multifaceted, depending on which specific GDB process is impaired.
Furthermore, it is possible to identify single impairments in GDB that may contribute to
different clinical profiles or subtypes of apathy. GDB allows people to be independent in
everyday task performance. This work will change the paradigm for assessing and treating
apathy, leading to improved diagnostic accuracy and effective interventions to improve the
ability of families, nurses, and other health professionals to manage a pervasive feature of ND.
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APPENDIX A: NEUROPSYCHIATRIC INVENTORY APATHY SUBSCALE
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